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In eukaryotes, gene expression is regulated by epigenetic modifications. Among these 
modifications, histone H3 lysine 4 (H3K4) methylation has been associated with 
transcription activation. Set1 is the sole H3K4 histone methyltransferase in 
Saccharomyces cerevisiae and functions in a multi-subunit protein complex (Set1C) to 
catalyze H3K4 mono-, di-, and trimethylation. In addition, mis-regulation of Set1 human 
orthologs such as MLL (1 to 4) or SETD1A/B have been linked to a variety of cancers 
such as leukemia and early embryonic development defects. The current model indicates 
that the Paf1 complex (RNA polymerase II associated factor I) recruits Set1C to the 
phosphorylated CTD of RNA polymerase II (RNAPII) and chromatin, so that Set1C can 
deposit histone H3K4 methylation at actively transcribed genes. Here we show that the 
Set1 and RNAPII association is independent of Paf1 complex subunits. Our results also 
show that Set1 and RNAPII can interact independently of Set1-associated subunits. We 
have identified, for the first time, the region responsible for the Set1 and RNAPII 
interaction and have named this region the Set1 RNA polymerase II interacting motif 
(SRIM), which is in the uncharacterized region upstream of the previously identified Set1 
RNA Recognition Motifs (RRM). Importantly, we have determined that Set1 interacts 
xvi 
 
with the Ser5 phosphorylated form of CTD and that the SRIM is necessary for this 
interaction. Additionally, SRIM mutants show altered enrichment at mostly the 5’ regions 
of open reading frames of actively transcribed genes, including PYK1 and PMA1 and 
inducible genes, including PCK1. Moreover, one SRIM mutant shows a great decrease in 
H3K4 trimethylation levels globally and gene specifically. Interestingly, the deposition of 
global H3K4 mono- and dimethylation still occurs in the SRIM mutants. Together, these 
results suggest that the Set1 and RNAPII interaction is important for proper recruitment 
of Set1 and the deposition of H3K4 trimethylation to 5’ ends of actively transcribed 
genes, whereas Set1 could also be recruited to chromatin through other mechanisms 
independent of the Set1-RNAPII interaction to deposit H3K4 methylation. Furthermore, 
the loss of Set1 and SRIM mutants show sensitivity to 6-azauracil (6AU) indicating that 
the Set1 and RNAPII interaction is important for transcriptional elongation. Taken 
together, these data indicate that Set1 specifically interacts with the Ser5 phosphorylated 
form of RNAPII through the newly identified SRIM and that this interaction plays a role 
in the establishment of Set1-mediated H3K4 methylation to actively transcribing genes 
and inducible genes. 
In the meanwhile, we have constructed the “N-ICE” plasmids so that non-
essential and essential genes can be N-terminally 3×FLAG tagged and expressed from an 
Inducible promoter (GAL1), Constitutive promoters (CYC1 or PYK1), or the Endogenous 
promoter. We have validated the N-ICE plasmid system by N-terminal tagging two non-






 Epigenetics and Chromatin 
 
1.1.1 Definition of Epigenetics 
The term “epigenetics” was first proposed by Dr. Conrad Hal Waddington when 
he studied embryogenesis in 1942 to define the study of causal mechanisms connecting 
genotype to phenotype (1, 2). In recent years, epigenetics has become an area of rapid 
growth, and the meaning of “epigenetics” has evolved from a general notion to a more 
specific term; epigenetics is now defined as the study of mechanisms that result in 
developmental changes in gene activities and effects that are not mediated by altering 
DNA sequences (2). These changes can be at different cellular levels and include DNA 
modifications, histone post-translational modifications, RNA-mediated epigenetic 
regulation, and cellular epigenetic inheritance (2-5).  
 
1.1.2 Chromatin structure and function 
One major difference between eukaryotic cells and prokaryotes is that eukaryotic 
genomic DNA is enclosed within a nuclear membrane in a structure termed nucleus. In 
the nucleus, DNA is highly condensed and packed with proteins to form a compact 




in two global forms, heterochromatin and euchromatin (8). Heterochromatin is a densely 
packed form of DNA that is associated with gene repression and silencing, whereas 
euchromatin is a loosely packed form of DNA that is associated with active transcription 
(8). The function of chromatin was originally believed to be packing DNA in the nucleus. 
Later, it was found that chromatin also plays important roles in preventing DNA damage 
and regulating gene expression (9). 
 
 Figure 1.1 Chromatin 
In the nucleus of eukaryotic cell, 146 base pairs of DNA are wrapped around a histone 
octamer, form a fundamental repeating unit called nucleosome. The histone octamer is 
composed of two copies of each core histone protein (H2A, H2B, H3, and H4). 
 
In the eukaryotic cell, chromatin is composed of a fundamental repeating unit 
called the nucleosome, where 146 base pairs of DNA are wrapped around a histone 
octamer (7). The histone octamer is composed of two copies of each core histone protein 
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(H2A, H2B, H3, and H4) (8, 10). In the histone octamer, H3 and H4 form a (H3-H4)2 
tetramer, and H2A and H2B form two heterodimers (8, 10). It has been suggested that 
nucleosome assembly occurs through the deposition of (H3-H4)2 tetramer onto the DNA 
followed by the rapid incorporation of two H2A-H2B dimers (11, 12). The histone 
octamers are linked by an interaction between H2B and H4 (8, 10). In addition to the core 
histones, histone H1 (or H5 in avian species) serves as a linker histone, which is essential 
for higher-order chromatin structures (8). To form a higher-order chromatin structure, the 
repeating structure of the nucleosome forms a 30-nm condensed chromatin fiber (8). The 
chromatin fibers are further packed into structures called chromosomes, which are visible 
during mitosis and meiosis (9).  
The core histones have two distinct regions: the highly ordered histone globular 
fold regions and the mostly unstructured N- or C-terminal histone tails (10, 13, 14). Both 
regions have important roles in nucleosome structure and stability. The histone fold 
regions are necessary for the interactions within histones that allow for histone octamer 
formation and for the interactions between histones and DNA (10, 13). The unstructured 
N-terminal tails of both H3 and H2B pass through the DNA superhelix channels and 
interact with neighboring nucleosomes, thus playing an important role in nucleosome 







 Chromatin Modulation  
1.2.1 ATP-dependent Chromatin Remodeler 
An ATP-dependent chromatin remodeler can regulate chromatin through several 
mechanisms, including sliding the nucleosomes along DNA, disassembling the histone-
DNA complex, evicting the nucleosome, and replacing histones with histone variants 
(17-19).  
There are four classes of ATP-dependent chromatin remodelers. The common 
feature of these four categories is that they all share a homologous ATPase catalytic 
domain, which functions in DNA binding and ATP hydrolysis (20, 21). The differences 
in these four classes are found in the other domains, which have specialized functions 
(20, 21). The first class of ATP-dependent chromatin remodelers is the SWI/SNF family, 
which contains a bromodomain (20, 21). The members of the SWI/SNF family interact 
with acetyl groups on the lysine residues of histone tails through the bromodomain (20, 
21). The members of this family mainly promote transcription by sliding nucleosomes 
along the DNA to enhance the interaction between the transcription factors and the DNA 
(20, 21). The second class is the ISW1 family, in which the enzymes function in 
regulating the space between nucleosomes (20, 21). The enzymes in this family usually 
function in chromosome assembly and gene repression (20, 21). The third class is the 
CHD family, in which the enzymes are characterized by the presence of a chromodomain 
(21). The chromodomain has been shown to interact with methylated histone lysine 
residues, and the CHD family has been shown to promote transcription by sliding or 
removing nucleosomes (4, 21). One exception is the Mi-2/NuRD complex, which 
represses gene expression by interacting with histone deacetylases and the H3K4 
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demethylase (22, 23). The last class is the INO80 family, in which the enzymes have 
diverse functions, including responding to DNA damage and regulating transcription (20, 
21).  
 
1.2.2 Histone Post-Translational Modifications  
One of the epigenetic mechanisms by which chromatin can be organized into 
active or repressed expression modes is the post-translational modification of core 
histones. The N- and C- terminal tails of the core histones are rich in lysine (K), arginine 
(R), and serine (S) residues, all of which can be chemically modified. The post-
translational modifications of methylation and acetylation were initially discovered on 
histones in the 1960s (24-28). Since then, over 100 distinct sites on histones that can be 
chemically modified have been identified (27, 29). These sites are mostly found on 
histone tails but can also be located in the histone fold domain (27, 29). The most well-
known histone modifications include lysine or arginine methylation, lysine acetylation, 
serine or threonine phosphorylation, lysine ubiquitination, and lysine sumoylation (26, 
27, 29). The post-translational modifications to histones can regulate chromatin structure 
by changing the chemical composition or charge or by serving as docking sites for other 
effector proteins (29). The histone post-translational modifications have important roles 
in chromatin structure, gene regulation, gene silencing, the DNA damage response, and 






Figure 1.2 Histone post-translational modifications 
The histone tails are rich in lysine, arginine, and serine residues, all of which can be 
chemically modified. The most well-known modifications include methylation, 
acetylation, phosphorylation, and ubiquitination. The post-translational modifications 
to histones can regulate chromatin structure through changing the chemical 
composition or charge or through serving as docking sites for other effector proteins 
 
1.2.2.1 Histone Acetylation, Phosphorylation, and Ubiquitination  
Histone acetylation, which is associated with active transcription, was the first 
histone post-translational modification identified and is the most studied (30-32). The 
acetylation of histones was first discovered in 1964 (28, 33). Later, histone 
acetyltransferases (HATs), which transfer an acetyl group from the cofactor acetyl-CoA 
to the lysine residues of histones (27, 34-36), were identified. Histone acetylation 
neutralizes the positive charges of the lysine residues on histone tails and, in doing so, 
decreases the interaction of the histone N-terminal tails with the negatively charged 
phosphate groups of the DNA (27, 37, 38). Consequently, the chromatin forms a more 
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relaxed structure, which exposes the DNA to transcription factors and RNA polymerases 
(27, 31, 38, 39). In addition, acetylated histones serve as docking sites for other 
functional proteins (40, 41). Bromodomain-containing proteins, including chromatin 
remodelers and transcription factors, bind to acetylated histones and modulate chromatin 
(27, 41, 42). The acetyl groups on histones can be removed by histone deacetylases 
(HDACs). Histone deacetylation results in a compact and condensed chromatin and 
consequently represses gene expression. There are four classes of HDACs that are based 
on functional similarity and sequence homology. Classes I, II, and IV share zinc-
dependent active sites that can be inhibited by trichostatin A, while Class III HDACs are 
NAD+-dependent proteins that are not inhibited by trichostatin A (34, 43). The yeast 
homologues of the Class I, II, and III families are Rpd3, Hda1, and Sir2, respectively 
(44). Class IV only contains one member, HDAC11, which does not have a homolog in 
yeast (44). 
Histone phosphorylation plays important roles in the response to genotoxic stress, 
the regulation of gene transcription, and the regulation of chromatin structure during 
apoptosis and cell division (45). The phosphorylation of H2A.X S139 in mammalian cells 
(or H2A S129 in yeast) plays a crucial role in DNA double-strand break repair in all of 
the phases of the cell cycle and DNA damage response, including replication-coupled 
DNA repair, homologous recombination (HR), and non-homologous end joining (NHEJ) 
(45-48). There are several other phosphorylation sites on histone residues that are related 
to the DNA damage or stress response. For example, histone variant H2A.X tyrosine (Y) 
142 is phosphorylated in a DNA damage-dependent manner; and histone H4 S1 
phosphorylation is triggered by DNA damage when yeast cells are exposed to UV light 
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and methyl methanesulfonate (MMS) (45, 49). In addition to the DNA damage response, 
the phosphorylation of histones also plays a role in crosstalk with other histone 
modifications, which allows for the proper control of chromatin remodeling and the 
regulation of gene expression (45). For example, histone H3 S10, threonine (T) 11, and 
S28 phosphorylation have been shown to be associated with transcriptional activation 
through Gcn5-dependent acetylation at H3 K9 and K14 (45, 50-52). Additionally, histone 
phosphorylation plays a role in chromatin compaction during mitosis and meiosis (45). 
For example, the phosphorylation of histone H3 T3, S10, T11, and S28 play a role in 
chromosome condensation and segregation (45, 52).  
Ubiquitination is a dynamic process that adds a 78-amino acid (8.5-kDa) ubiquitin 
protein onto a lysine residue of target protein (53, 54). This process requires three steps: 
ubiquitin is first activated by E1, conjugated to the ubiquitin-conjugating enzyme E2, and 
finally transferred to the target lysine residue of the substrate with the help of a ubiquitin-
protein isopeptide ligase (E3) (53, 54). A substrate can be polyubiquitinated or 
monoubiquitinated. Polyubiquitination usually results in the substrate being targeted for 
26S proteasome degradation, while monoubiquitination primarily marks the substrate for 
a special function (53, 54). Chromosomes are monoubiquitinated at histones H2A and 
H2B (55). In higher eukaryotes, histone H2A and histone variant H2A.Z have been 
identified as targets for ubiquitination, but their ubiquitination is not detected in 
Saccharomyces cerevisiae (56). H2A ubiquitination is related to the repression of gene 
expression through the regulation of chromatin structure and the repression of histone 
H3K4 methylation (56). The monoubiquitination of H2B occurs on yeast H2B K123 
(K120 in mammalian cells) and is mostly associated with active transcription since the 
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large size of ubiquitin switches the higher-order structure of chromatin to a more open 
conformation (55). H2B monoubiquitination is catalyzed by Rad6 (E2) and Bre1 (E3) in 
yeast, and H2B monoubiquitination is involved in the crosstalk between H3 K4 and K79 
methylation (57-59). H2B ubiquitination plays a crucial role in gene transcription, gene 
silencing, and DNA damage repair during various cellular processes, including the cell 
cycles, apoptosis, development, and tumorigenesis (57-60). 
 
1.2.2.2 Histone Methylation  
Histone methylation was discovered and identified as a stable modification on 
histones in 1964 (33, 61). Histone methylation is carried out by transferring methyl 
groups from the cofactor S-adenosyl-L-methionine (SAM) to lysine, arginine, or 
glutamine residues on the histone (61-64).  
 
Of the three amino acids that can be methylated, histone lysine methylation has 
been the most studied (65). In human cells, histone lysine residues can be methylated in 
three states (mono-, di-, or trimethylation), and the major sites of methylation are K4, K9, 
K27, K36, and K79 on histone H3 and K20 on histone H4 (64, 66). Methylation on 
H3K4, K36, and K79 is mainly associated with active transcription, and methylation on 
H3K9 and K27 and H4K20 is primarily associated with gene repression and silencing 
(37, 63, 64, 66). In S. cerevisiae, the major methylation sites are on histone H3K4, K36, 
and K79 and are primarily associated with active transcription (64, 66). Intriguingly, 
methylation on histones H3K9 and K27, which is mainly associated with gene repression 
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and silencing, has not been identified in S. cerevisiae (66). One recent study identified 
histone H4K20 monomethylation in S. cerevisiae and found that it functioned in 
subtelomeric silencing (67). However, the histone methyltransferase (HMT) for this site 
has not been identified in S. cerevisiae, and there have been no follow-up studies (67). 
Recent studies have identified Set5 as the a HMT responsible for the monomethylation of 
histones H4K5, K8, and K12 in S. cerevisiae (68, 69).  
 
 Figure 1.3 Histone H3 and H4 methylation sites in Saccharomyces cerevisiae 
In Saccharomyces cerevisiae, Set1 complex, Set2, and Dot1 methylate H3K4, K36, 
K79 respectively. All three markers have been associated with positive transcription. 
Recent study shows Set5 can monomethylate H4 K5, K8, and K12. 
 
Histone methylation is catalyzed by histone lysine methyltransferases (KMTs) 
using SAM as a cofactor (6, 70). Most KMTs contain a SET domain in their catalytic 
core, except for yeast Dot1 (human DOT1L), the KMT for histone H3K79 (64, 70). The 
catalytic domain of Dot1 shares protein sequence similarity to histone arginine 
11 
 
methyltransferases, even though Dot1 has not been identified as a histone arginine 
methyltransferase (71, 72).  
Histone lysine methylation is both a stable and dynamic modification, and the 
methyl groups can be removed from lysine by histone lysine demethylase (HDM) (73). 
There are two families of HDM that have been identified, the LSD family and the JmjC 
family (74). The LSD family demethylates histones through a FAD (flavin adenine 
dinucleotide)-dependent amine oxidase reaction (74). The LSD homologues are not 
found in S. cerevisiae (75). The JmjC domain family demethylates histones through a 
2OG-Fe(II)-dependent dioxygenase reaction, and this motif is conserved from yeast to 
humans (74). In S. cerevisiae, Jhd2, a JmjC domain-containing demethylase, can remove 
histone lysine methylation on H3K4 (76-78).  
The additional methyl groups on histones do not change the positive charge of 
lysine or arginine (65). Rather, methylated histones mainly serve as docking sites for 
protein-protein interactions that regulate chromatin structure and gene expression, such as 
those encoding chromatin remodelers, enzymes required for the post-translation 
modification of histones, and transcription factors (65, 79-82). The specific binding 
domains for histone lysine methylation include WD40 domains, chromodomains, Tudor 
domains, and PHD fingers (81, 83). For example, human HP1, a chromodomain-
containing protein, is reported to bind methylated H3K9 and function in DNA 
methylation and RNA-mediated silencing (84). In addition, yeast Set3, a PHD finger- and 
SET domain-containing protein, has been shown to interact with H3K4 dimethyl groups 





 Figure 1.4 H3K4 trimethylation cross-talks with other histone modifications 
(A) H3K4 trimethylation promote H3 acetylation and inhibit H3K9 methylation. (B) 
The Rad6 and Bre1 mediated Histone H2B monoubiquitination is required for H3K4 
and K79 methylation.  
Histone arginine methylation can be associated with either transcriptional 
activation or repression and is mediated by protein arginine methyltransferases (PRMTs) 
that deposit methyl groups on histone H3R2, R8, R17, and R26 and H4R3 (37, 88, 89). 
The PRMTs catalyze three forms of arginine methylation: monomethylation, asymmetric 
dimethylation, and symmetric dimethylation (88). Recent studies have shown that 
JMJD6, a JmjC domain-containing protein, is a putative demethylase of histone H3R2 
and H4R3 dimethylation (88, 90). Additionally, there is a PADI4-mediated deamination 
reaction that converts an arginine to citrulline to prevent the methylation (91). Histone 
glutamine methylation was recently identified on H2A glutamine (Q) 104 in humans (and 
Q105 in yeast) and was found to be exclusively enriched at the 35S ribosomal DNA 
(rDNA) locus (62). In yeast, H2A glutamine methylation is mediated by Nop1 to prevent 
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the recruitment of FACT to the 35S rDNA locus and results in a more open chromatin 
conformation (62).  
1.2.2.3 Histone H3 Lysine 4 Methylation 
Histone H3 Lysine 4 (H3K4) methylation is one of the most well-studied post-
translational modifications. H3K4 methylation is conserved from yeast to humans and is 
generally considered to be a hallmark of active gene transcription (29, 92). Genome-wide 
studies have found that the pattern of H3K4 trimethylation enrichment is strongly 
correlated with actively transcribed regions from yeast to humans. In yeast, H3K4 mono-, 
di-, and trimethylation are mainly enriched on the open reading frames (ORFs) of active 
genes (29, 92). H3K4 trimethylation is predominately enriched at the transcriptional start 
sites and at the 5’ ends of the ORFs of active genes (29, 92). H3K4 dimethylation is 
mainly enriched in the middle of the ORFs, and monomethylation is enriched at the 3’ 
ends of active genes (29, 92).  
H3K4 methylation sites serve as molecular docking sites for the recruitment of 
effector proteins. (81, 93, 94) H3K4 methylation either activates or represses 
transcription depending on the function of the effector protein (81, 94). For example, 
CHD1, a chromodomain-containing and H3K4 di- and trimethylation-interacting protein, 
alters gene expression by recruiting SAGA HAT complexes (95, 96). Alternatively, Set3 
interacts with H3K4 dimethylation and functions in histone deacetylation and subsequent 
gene repression (85-87).  
As a part of the “histone code,” histone H3K4 methylation is involved in crosstalk 
with other histone modifications (63, 81, 94). The enrichment of H3K4 methylation is 
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correlated with the location of histone acetylation (64, 87). H2BK123 monoubiquitination 
(H2Bub) in S. cerevisiae is related to H3K4 methylation through a trans-tail mechanism 
(57, 59). In contrast, the location of H3K4 methylation could prevent the presence of 
other modifications, such as H3K9 methylation on the histone tails (64, 97). 
 
 Set1: the SET-domain Containing Protein 
 
1.3.1 SET-domain Containing Proteins 
The SET domain is an evolutionarily-conserved motif of approximately 130 
amino acids (98). It was named after the three original Drosophila proteins, Su(var)3-9, 
enhancer-of-zeste, and Trithorax (99). The SET domain mainly functions as a catalytic 
domain in most KMTs (except for Dot1) and acts by transferring a methyl group from 
SAM to the ε-amines of lysine residues on histone tails (100). The SET domain is flanked 
on either side by less-conserved n-SET (or pre-SET) and post-SET domains. The n-SET 
domain stabilizes the SET domain, and the disordered post-SET domain has been shown 
to be associated with the SAM cofactor and histone tails (101, 102). The SET domain 
forms a specific fold pseudoknot structure and creates an active site in which a zinc ion is 
coordinated to three conserved cysteine residues in the post-SET domain (101, 102). In S. 
cerevisiae, there are seven SET domain-containing proteins, named Set1 to 6 and Pkm4 
(103, 104). Pkm4 was originally named Set7 and was later identified as a ribosomal 
lysine methyltransferase that targets lysine 55 of Rpl42ap and Rpl42bp (104). Set1, Set2, 
and Set5 have been identified as histone methyltransferases that target H3K4; H3K36; 
and H4K5, K8, and K12, respectively (68, 69, 103, 105). Although Set3 also contains a 
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SET domain, the methyltransferase activity of Set3 has not been identified. Instead, Set3 
has been shown to bind to H3K4 dimethylation sites and function as a subunit of the 
histone deacetylase complex (87). The functions of Set4 and Set5 have not been 
identified. 
 
Figure 1.5 Schematic representation Domain structures of SET domain 
containing proteins in yeast 
 
1.3.2 Set1: the Histone H3K4 Methyltransferase in Saccharomyces cerevisiae 
The first H3K4 methyltransferase identified was Set1 in Saccharomyces 
cerevisiae. After analyzing individual deletion strains for each of the seven SET domain-
containing proteins in Saccharomyces cerevisiae, Set1 was found to be the only protein 
responsible for H3K4 methylation (103). This and the following results demonstrated that 
Set1 is the sole H3K4 methyltransferase that is responsible for H3K4 mono-, di-, and 
trimethylation in S. cerevisiae (103, 106-108). Unlike other yeast HMTs, such as Set2 
and Dot1, Set1 must be present in a multi-protein complex for it to be active in vitro and 
in vivo (92, 106). In S. cerevisiae, the Set1 complex (Set1C) or Complex of Proteins 
Associated with Set1 (COMPASS) consists of eight members: Set1, Bre2, Sdc1, Swd1, 
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Swd2, Swd3, Spp1, and Shg1 (106, 107, 109). The Bre2, Sdc1, Swd1, Swd3, and Spp1 
subunits are required for various degrees of proper H3K4 methylation, and Swd1, Swd2, 
Swd3, and Spp1 have been shown to be important for regulating Set1 protein levels, 
suggesting that these subunits may contribute to Set1 protein stability (106, 107, 109, 
110). A recent study showed that Set1 methylates a non-histone target, the kinetochore 
protein Dam1 (111, 112). 
Following the identification of yeast Set1, the human Mixed Lineage Leukemia 
family (MLL1 through 4) and human SET1A and SET1B were identified as yeast Set1 
homologues. All of the human H3K4 methyltransferases form complexes and share most 
of the core subunits that are homologous to subunits of the yeast Set1 complex (82). The 
core subunits consist of ASH2 or ASH2L (Bre2 homolog), DPY30 (Sdc1 homolog), 
RBBP5 (Swd1 homolog), WDR82 (Swd2 homolog), WDR5 (Swd3 homolog), and CFP1 
or CGBP (Spp1 homolog) (82). WDR82 has only been identified in human SET1 
complexes and not in MLL complexes (82). Similar to that observed in yeast, disruptions 
of the human MLL(1-4)/SET1A/B complex subunits WDR5, RBBP5, and ASH2L reduce 
H3K4 trimethylation. These results suggest that studying yeast Set1C can help us 
understand how human H3K4 methyltransferase complexes function.  
As the catalytic core of Set1C, Set1, a 1080-amino acid protein, consists of two 
putative N-terminal RNA recognition motifs (RRM1 and 2, amino acids 210-335 and 
415-568, respectively), an n-SET domain (787-935 a.a.), a SET domain (936-1063 a.a.), 
and a post-SET domain (1064-1080 a.a.) (106, 113, 114). The SET domain is a catalytic 
domain and is necessary for histone methyltransferase activity (113). A deletion or 
mutation in the n-SET or post-SET domain also results in the loss of all histone H3K4 
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methylation (113). The n-SET domain contains a motif of basic patch residues that is 
necessary for the association of Set1 with Swd1 (110). Interestingly, a Set1 truncation 
mutant containing the n-SET domain, SET domain, and post-SET domain can associate 
with the Set1C subunits, Spp1, Bre2, Sdc1, Swd1, and Swd3 and is the minimal unit 
necessary for global H3K4 trimethylation in vivo and in vitro (115, 116). However, the 
truncated Set1 was expressed at a higher level than endogenous Set1, thus, global H3K4 
trimethylation in vivo may be due to a gain of function. Set1 contains two putative RRM 
domains in the N-terminus. Interestingly, human Set1A and Set1B also contain a 
conserved RRM domain, while MLL1-4 does not (117). It was originally thought that the 
function of the RRM domain is to bind RNA, but it was later discovered that some RRM 
domains can promote protein-protein interactions (113). The deletion of RRM1 of Set1 
results in a loss of H3K4 trimethylation but has little effect on di- and monomethylation 
(113). One study showed that the RRM1 and RRM2 domains together can non-
specifically interact with RNA, whereas the RRM1 domain alone cannot (118). Human 
SET1A and SET1B contain only one RRM domain, and one study showed that the N-
terminus of human SET1A that contains the RRM domain can interact with Ser5-
phosphorylated CTD peptides with the help of Wdr82 (Swd2 homolog in humans) in 
vitro (117). Further studies are needed to elucidate the function of RRM domains in 
yeast. 
In Set1C, Bre2 and Sdc1 form a heterodimer and have related functions. The 
deletion of either BRE2 or SDC1 results in a loss of global H3K4 trimethylation and a 
decrease in mono- and dimethylation (106, 107, 109, 110). Bre2, a 505-amino acid 
protein, is the second largest subunit in Set1C. Sdc1, a 17-amino acid protein, is the 
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second smallest subunit in Set1C (106). Bre2 is composed of two domains, an N-terminal 
SPRY domain and a C-terminal SDI domain (119). The function of the SPRY domain in 
yeast is unknown, but a study has shown that the SPRY domain in human ASH2L (Bre2 
homolog) is required for the interaction of ASH2L with human RBBP5 (Swd1 homolog) 
and the cofactor SAM. (120, 121). The SDI domain of Bre2 has been shown to interact 
with the Dpy-30 domain of Sdc1 (119). 
Set1C has three WD40 repeat-containing subunits, Swd1 (426 a.a.), Swd2 (329 
a.a.), and Swd3 (315 a.a.). The WD40 domain has been shown to form a β-propeller 
structure that is involved in protein-protein interactions (114, 122). The deletion of either 
SWD1 or SWD3 causes a loss of all levels of H3K4 trimethylation and a significant 
decrease in Set1 protein levels (106, 107, 109, 110). A possible explanation for this is 
that Swd1 and Swd3 form a heteromeric complex independent of Set1, and the deletion 
of either one will therefore result in Set1 losing its interaction with the other (106, 110, 
114). In addition to the WD40 domain, the C-terminus of Swd1 contains two acidic 
patches that are necessary for its association with the basic patches within the n-SET 
domain of Set1 (110). These two acidic patches are also required for H3K4 methylation 
and Set1 protein stability (110). The function of Swd3 in Set1C activity has not been 
identified. Studies have shown that the human WDR5 (Swd3 homolog) interacts with the 
K4 residue on the H3 tail (123). Swd2 is an essential gene and is also a member of the 
APT cleavage and polyadenylation factor complex (106). Conditional mutations suggest 
that Swd2 is needed for proper H3K4 trimethylation (124).  
Spp1 (353 a.a.) is a PHD finger-containing protein. The deletion of SPP1 results 
in a modest reduction in both H3K4 trimethylation and Set1 protein levels (106, 107, 
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109, 110, 124, 125). An in vitro peptide-protein binding assay showed that Spp1 can 
interact with histone H3K4 di- and trimethylated peptides through its PHD finger and that 
Spp1 can interact with DNA via its C-terminus (126, 127). Spp1 is associated with the n-
SET domain of Set1 (115). However, the biological function of Spp1 needs further 
characterization. 
Shg1 (142 a.a.) is the smallest subunit of Set1C. The function of Shg1 is unknown, 
and there is no human homolog of Shg1. The deletion of SHG1 does not affect H3K4 
methylation (110). Shg1 directly associates with Set1 (356-568 a.a.), which is a region of 
Set1 RRM2. However, the biological function of this interaction is still unknown (115). 
Before Set1 enzymatic activity was identified, studies in yeast showed that Set1 is 
needed for normal yeast morphology and growth and for gene silencing at rDNA, 
telomeres, and mating-type loci (103, 107, 108, 113, 128). However, a later-proposed 
mechanism suggested that H3K4 trimethylation prevents Sir2 HDAC complex from 
spreading at these silencing regions; without H3K4 trimethylation, the Sir proteins 
titrated away from silent chromatin, causing loss of silencing (129, 130). The most recent 
studies have shown that the deletion of SET1 results in growth defects during the 
response to various types of stress, such as DNA damage and oxidative stress (131, 132). 
Set1 also regulates gene expression in the ergosterol pathway (133). The antifungal drug 
Brefeldin A (BFA) targets the yeast ergosterol pathway, and the deletion of SET1 or Set1 
complex subunits results in sensitivity to BFA at different degrees (133). Further studies 
are needed to understand the other biologically relevant roles of Set1 and H3K4 




 RNA polymerase II and Set1 
In eukaryotic cells, the process of gene transcription is executed by three DNA-
dependent RNA polymerases (134). RNA polymerase II (RNAPII) is the most studied 
and functions in the transcription of pre-mRNA and small nuclear RNA (134). RNAPII is 
conserved in eukaryotes and has a total molecular weight of approximately 550 kDa 
(134). RNAPII is composed of 10-12 subunits (12 subunits in yeast and humans) (134, 
135). RNAPII is composed of a core enzyme of 10 subunits and a peripheral Rpb4/7 
subcomplex (135). The Rpb4/7 subcomplex can be dissociated from purified RNAPII and 
has been shown to stimulate the selective initiation of RNAPII (134, 135). 
 
1.4.1 The Phosphorylation on CTD of RNA polymerase II 
The C-terminal domain (CTD) of RNAPII is on its largest subunit, Rpb1, which is 
composed of heptapeptide repeats of (Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7). There are 
26 repeats in yeast and 52 repeats in mammals (136). The CTD is essential for viability, 
although the number of repeats can be reduced (137-139). The CTD is also essential for 
cell growth. Yeast require at least 10 CTD repeats for viability, and a yeast strain 
containing only 10-12 CTD repeats has a strong temperature-sensitive growth defect 
(137-139). In the pre-initiation complex, RNAII with an unphosphorylated CTD is loaded 
on chromatin (140). The CTD is then modified at multiple sites, mostly by 
phosphorylation, so that the CTD codes will be presented at the different stages of 
transcription (140). The different CTD codes will recruit stage-specific factors that play 
important roles in transcription and CTD modification (140). The most studied CTD 
modifications are phosphorylation at Ser2, 5, and 7 (140). Phosphorylated Ser5 and Ser7 
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occur at the transcription start site in the 5’ region, Ser5 phosphorylation is replaced by 
Ser2 phosphorylation during transcription elongation so that Ser2 phosphorylation is 
enriched at the 3’ ends of the ORF, and Ser7 phosphorylation remains at high levels 
across the ORF (140). At the transcription start site, Ser5 is phosphorylated by Kin28 
(CDK7 in humans) and Srb10 (CDK8 in humans), and Rtr1 is the phosphatase 
responsible for the removal of Ser5 phosphorylation shortly after initiation (140). Kin28 
also phosphorylates Ser7 at the transcriptional start site, and the kinase Bur1 is 
responsible for maintaining Ser7 phosphorylation at the 3’ end (140). Throughout the 
elongation process, Ctk1 is the primary kinase for Ser2 phosphorylation. Bur1 (CDK9 in 
humans) is also a Ser5-P-dependent Ser2 kinase, and Ser2-P and Ser5-P can co-exist on 
the CTD, and this is important for recruiting elongation regulators, such as Set2 (140, 
141). Fcp1 dephosphorylates Ser2-P upon the termination of transcription. The remaining 
phosphorylated Ser5 and Ser7 sites at the 3’ end are removed by the phosphatase Ssu72 
(140). 
There are other modification sites on the CTD. Tyr1 is phosphorylated both in 
human cells and yeast, although the yeast kinase has not been identified (142). Tyr1 is 
phosphorylated along with Ser2-P, but Tyr1-P is decreased upstream of the poly-A region 
(142). Tyr1-P has been shown to enhance the binding of elongation factors and to prevent 
the recruitment of termination factors (140, 142). Thr4 can also be phosphorylated. The 
Thr4 substitution does not affect yeast growth; however, it is lethal to higher eukaryotes 
(140, 143). Other types of modifications have either not been shown in yeast or have 





Figure 1.6 Phosphorylation of CTD of RNA Polymerase II (RNAPII) and 
transcription. 
(A) CTD is phosphorylated in different steps of transcription. The largest subunit of 
RNAPII, Rpb1 containing a flexible C-terminal domain (CTD) which consists of 
multiple repeat of 7 amino acids (Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7). Before 
RNAPII is loaded on to the chromatin, the serine amino acids are not phosphorylated. 
After RNAPII recruited to transcriptional start site, Ser5 and Ser7 are phosphorylated, 
in yeast the kinase is Kin28. When the RNAPII move along the DNA, called 
elongation, the Ser5 phosphorylation is removed and Ser2 is phosphorylated. And 
when RNAPII approaching to 3’ of gene and forming termination complex, all the 
serine phosphorylation on the CTD is removed. (B) The pattern of CTD 
phosphorylation on the open reading frame of active gene. Ser5-P is enriched at TSS 
and 5’ ends, Ser2-P is enriched at 3’ ends of ORF, and Ser7-P is enriched over the 
ORF. 
 Phosphorylation of the RNAPII CTD functions along with histone modifications 
to regulate gene transcription. It has been shown that Ser5-P associates with the Set1 
complex (140). Thus, Set1 and H3K4 trimethylation were found by chromatin 
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immunoprecipitation (ChIP) analysis to be highly enriched at actively transcribed genes 
near the 5’ ends of coding regions (140). During elongation, Ser5-P and Ser2-P both 
associate with Set2 and methylate H3K36. H3K36 trimethylation, which functions in 
transcription termination and prevents cryptic transcription, is primarily enriched at the 3’ 
end (140).  
1.4.2 RNA Polymerase II Association Factor (Paf1) Complex and Set1 
The RNA polymerase II association factor complex I (Paf1C) is composed of five 
subunits, Paf1, Ctr9, Cdc73, Rtf1, and Leo1 in yeast and is conserved from yeast to 
humans (144-146). The Paf1 complex plays important roles in multiple steps of 
transcription, including transcription elongation, the transcription-related modification of 
histones, and the termination of mRNA synthesis (147). Paf1C is localized to the open 
reading frames of active genes and genetically and physically interacts with RNAPII and 
elongation factors, such as Spt5 (147). Mutations in Paf1C lead to sensitivity to the base 
analog 6-azauracil (6-AU) and mycophenolic acid, both of which affect transcription 
elongation (147). Additionally, the Paf1 complex regulates the recruitment of the E2 
ubiquitin-conjugating enzyme Rad6 and the E3 ubiquitin ligase Bre1 to active genes to 
monoubiquitinate H2B, which is a requirement for H3K4 and H3K79 trimethylation by 
Set1C and Dot1 (148). The trimethylation of H3K36 also requires Paf1C, which plays an 
important role in the repression of cryptic transcription (147). Paf1C is also required for 
proper 3’ end processing and the termination of mRNA and snoRNA transcription (149). 
 
The Paf1 complex has been shown to genetically interact with the Set1 complex, as 
double-deletion of the Paf1 and Set1 complex subunits causes synthetic lethality in yeast 
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(150) The current model suggests that the Paf1 complex recruits the Set1 complex to 
interact with the Ser5-phosphorylated CTD of RNAPII (150-152). However, this model 
is based on the Paf1 complex-dependent interaction between RNAII and Bre2, a Set1 
complex subunit, rather than on the detection of a direct interaction between Set1 and 
RNAPII (150-152). Without Bre2, the yeast still has partial global H3K4 
monomethylation and dimethylation (110). Further investigations are needed to elucidate 
the relationship between the Paf1 and Set1 complexes.  
 
 
Figure 1.7 The model of Paf1 Complex is required for H3K4 methylation.  
(A) The Paf1 complex plays important roles in multiple steps of transcription. It 
interacts with RNAPII and elongation factors for example Spt5. It also required for 
Rad6 and Bre1 mediated H2B ubiquitination, which is required for H3K4 
trimethylation. (B) The current model suggests Set1 complex is recruited to Ser5-P 




CHAPTER 2.  THE ROLE OF THE SET1 RNA POLYMERASE II INTERACTING 
MOTIF (SRIM) IN SET1 RECRUITMENT AND HISTONE H3K4 
METHYLATION
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In the eukaryotic cell, gene expression is highly regulated by epigenetic 
modifications, including methylation, acetylation, phosphorylation, and ubiquitination. 
Among these modifications, histone H3 lysine 4 (H3K4) methylation has been associated 
with active gene transcription (64, 92). In S. cerevisiae, Set1 is the sole histone 
methyltransferase responsible for H3K4 mono-, di-, and trimethylation (103, 106-108). 
H3K4 trimethylation (H3K4me3) is primarily enriched at the transcriptional start site and 
5’ end of the open reading frame (ORF), H3K4 dimethylation (H3K4me2) is mainly 
enriched in the middle of the ORF and H3K4 monomethylation (H3K4me1) is enriched 
in 3’ of the ORF(153-155). Recent studies into the function of these methylation events 
show they act as binding sites to recruit effector proteins (81, 93, 94). Depending on the 
function of the effector protein, they can elicit a response to help activate or repress gene 
transcription (85-87, 95, 96). 
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Unlike other yeast histone methyltransferases such as Set2 and Dot1, Set1 
functions in a complex with seven other subunits (Bre2, Swd1, Spp1, Swd2, Swd3, Sdc1, 
and Shg1), together called Set1 complex (Set1C or COMPASS) (106, 107, 109). The 
Set1C subunits are important for Set1 catalytic activity in vitro and in vivo (92, 106). The 
human homologs of Set1 include the Mixed Lineage Leukemia family (MLL1-4) and the 
human SET1 family (Setd1A and Setd1B). All of the human H3K4 methyltransferases 
form complexes and share most of the core subunits that are homologous to subunits of 
the yeast Set1 complex (82, 152). As the catalytic core of Set1C, Set1, a 1080-amino acid 
protein, consists of two putative N-terminal RNA recognition motifs (RRM1 and 2, 
amino acids 210-335 and 415-568, respectively), an n-SET domain (797-933 a.a.), a SET 
domain (933-1063 a.a.), and a post-SET domain (1064-1080 a.a.) (106, 113, 114). The 
function of RRM domains are generally thought to bind RNA, but it was later discovered 
that some RRM domains can participate in protein-protein interactions (113). The RRM1 
domain of Set1 is required for H3K4 trimethylation and Set1 stability (113). The RRM2 
domain of Set1 has been shown to be potentially associated with RNA (118). 
Interestingly, human Set1A and Set1B also contain only one conserved RRM domain, 
while MLL1-4 does not (117). The study showed that the N-terminus of human SET1A 
that contains the RRM domain can interact with Ser5-phosphorylated (Ser5-P) CTD 
peptides with the help of Wdr82 (Swd2 homolog in humans) in vitro (117). MLL1 and 
MLL2 have also been shown to interact with Ser5-P CTD. (156, 157) 
The C terminal domain (CTD) of RNAPII is on its largest subunit, Rpb1, which is 
composed of heptapeptide (Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7) repeats, and there are 
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26 repeats in yeast and 52 repeats in mammals (158). During transcription initiation and 
elongation, RNAPII successively recruits stage-specific factors, by Serine 
phosphorylation on the CTD (159). In yeast, Serine 2, 5, 7 can be phosphorylated. Ser5 
phosphorylated (Ser5-P) CTD is enriched at the transcription start site 5’ region; and 
during transcription elongation, Ser5 is dephosphorylated and Ser2 is phosphorylated; 
Ser7 phosphorylation is enriched across the ORF (160). Set2 directly interacts with CTD 
phosphorylated at both Ser2 and Ser5 of RNAPII through its Set2 RNA polymerase II 
interaction (SRI) domain, which help to recruit Set2 to middle and 3’ end of ORF to 
deposit H3K36 trimethylation (141). Set1 has been shown to interact with Ser5-P CTD of 
RNAPII, however, it is still unclear how this interaction occurs and whether Ser5-P CTD 
of RNAPII helps the deposition of H3K4 trimethylation on ORF (161). The study of how 
yeast Set1 associates with RNAPII will help us understand the mechanism of Set1 
recruitment and H3K4 methylation deposition.  
Paf1C functions in the transcriptional elongation complex, which is composed of 
five proteins: Paf1, Leo1, Rtf1, cdc73, and Ctr9 (144-146). Paf1C is genetically linked to 
Set1C, and double deletion of Paf1C subunits and Set1C subunits causes synthetic 
lethality in yeast (150). Paf1C recruits Rad6 and Bre1 to chromatin to perform 
monoubiquitination on H2B K123, which is required for H3K4 trimethylation (162). The 
current model claims that Paf1C recruits Set1C to interact with Ser5-P CTD of RNAPII. 
Characterizing whether Paf1C affects Set1 and RNAPII containing P-Ser5 CTD 





2.3.1 Set1 interacts with RNAPII containing Ser5-P and/or Ser7-P CTD and this 
interaction is independent of Paf1C subunits and most Set1C subunits 
Set1 has been shown to be associated with the Ser5-P CTD of RNAPII (161), 
however, the specificity of this interaction is still unclear. Thus, we generated an N-
terminal 3×FLAG tagged endogenously expressed SET1 strain. The whole cell extracts of 
indicated strains were immunoprecipitated using α-FLAG (M2) conjugated magnetic 
beads and analyzed by Western blot using antibodies against specific Serine 
phosphorylation on CTD of RNAPII. As shown in Figure 2.1A, Set2, as a positive 
control, interacts with not only Ser2-P and Ser5-P CTD of RNAPII as previous 
published, but also Ser7-P CTD of RNAPII, which is a novel discovery (141). In contrast, 
Set1 interacts RNAPII containing Ser5-P and/or Ser7-P CTD, not Ser2-P. To rule out the 
possibility that CTD antibodies may cross-react with other Serine phosphorylated forms 
of CTD, in addition to the antibodies of H5 (α-Ser2P) and H14 (α-Ser5P) used in Figure 
2.1A, we also applied another α-Ser5P antibody (3E8) to the blot and the result is similar  
(163). The set2 mutant without Set2 Rpb1 interacting (SRI) domain is used as a negative 
control (141).  
Previous studies in our lab and others have shown some Set1C subunits are 
required for proper Set1 functions as histone H3K4 methyltransferase (106, 110, 114, 
119). It is possible that Set1 interacts with RNAPII through Set1C subunits. To 
investigate whether Set1 is required for Set1C subunits interact with RNAPII, all Set1C 
subunits were C-terminal 3×FLAG tagged in both wild-type and set1∆ strains. The whole 
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cell extracts of these strains were prepared and subjected to α-FLAG (M2) 
immunoprecipitation assay and analyzed by Western blot using α-Ser5P (H14) and 
Rabbit α-FLAG antibodies. The result indicated that all Set1C subunits can interact with 
RNAPII containing Ser5-P CTD, and these interactions are abolished when SET1 is 
deleted (Figure 2.1B). The loss of interactions is not due to degradation of subunits 
without Set1, for the protein levels of each subunits remain the same in the set1Δ strains 
compared to SET1 strains (Figure 2.1B). These results demonstrate that Set1 is necessary 
for Set1C associating with RNAPII containing Ser5-P CTD.  
After we identified Set1 is required for Set1C interacting with RNAPII, we 
wanted to determine whether Set1C subunits are required for Set1 to interact with 
RNAPII. Thus, bre2∆, swd1∆, swd3∆, spp1∆, sdc1∆, and shg1∆ were generated in 
3×FLAG-SET1 strain. Because SWD2 is essential for yeast to grow, we did not test the 
dependency of Swd2 (152). The whole cell extracts of indicated strains were prepared 
and subjected to α-FLAG (M2) immunoprecipitation assay and analyzed by Western blot 
using α-Ser5P (H14) and α-FLAG (M2) antibodies. As shown in Figure 2.1C, Set1 still 
interacts with RNAPII containing Ser5-P CTD in all tested deletion strains. Though the 
immunoprecipitated Ser5-P CTD levels were decreased in swd1∆, spp1∆, and swd3∆, and 
shg1∆, the immunoprecipitated Ser5-P CTD levels are correlated with the Set1 protein 
levels in corresponding strains. This data indicates that the Set1-RNAPII interaction is 




Associated with RNAPII and crucial for transcription elongation, Paf1C is 
composed of five subunits, Paf1, Leo1, Rtf1, cdc73, and Ctr9 (144-146). Current model 
in the field indicates Set1-RNAPII interaction is mediated by Paf1C (150-152). To 
determine whether Paf1C is required for Set1 to interact with RNAPII, individual Paf1C 
subunit deletions, paf1∆, ctr9∆, cdc73∆, rtf1∆, and leo1∆, were generated in 3×FLAG-
SET1 strain. The immunoprecipitation assay was performed as described in Figure 1C. 
To our surprise, Set1 still interacts with RNAPII containing Ser5-P CTD in all individual 
Paf1C subunit deletion strains (Figure 2.1D). We also determined the global levels of 
H3K4 mono-, di-, and trimethylation and H2B ubiquitination in our Paf1C subunit 
deletion strains, and the results are same as published results (Figure 2.1E). Our result 
indicates that the Set1-RNAPII interaction is independent of Paf1C.  
2.3.2 A novel domain in the N terminus of Set1 mediates Set1 and RNAPII interaction.  
Given that Set1 and RNAPII interaction is independent of Paf1C subunits and 
most Set1C subunits, we sought to identify the region on Set1 responsible for this 
interaction. Yeast CEN constructs were generated that encode 3×FLAG tagged full length 
or truncated Set1, and the Set1 protein is expressed from SET1 promoter (-400 to -1bp) 
(Figure 2.2A). The indicated constructs were transformed to set1∆ strain, and whole cell 
extracts of indicated strains were immunoprecipitated as described in Figure 2.1C. 
Interestingly, as shown in Figure 2.2B, the N terminus of Set1 (set11-689 and set11-375) 
interacts with RNAPII containing Ser5-P CTD, whereas the C terminus of Set1 (set1690-
1080 and set1380-1080) fails to. This result indicates that set11-375 is necessary and sufficient 
to interact with RNAPII containing Ser5-P CTD. To further define the Set1-RNAPII 
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interacting sites, Set1 constructs with sequential N-terminal truncations were generated 
(Figure 2.2C). The constructs were transformed and tested for RNAPII interaction 
through immunoprecipitation assay as described in Figure 2.1C. As shown in Figure 
2.2D, set1102-1080 still interacts with RNAPII containing Ser5-P CTD, while Set1151-1080 
and Set1211-1080 fail to. This result indicates that the amino acids 102-151 of Set1 are 
required for Set1 and RNAPII interaction. Given set11-375 is necessary and sufficient for 
Set1-RNAPII interaction and we want to further narrow down the Set1 region that is 
sufficient for RNAPII binding, more truncations in amino acids 1-375 of Set1 were 
generated. Although set11-375 is a stable truncation, the further truncations were found to 
be poorly expressed. Thus, 2-micron overexpression constructs of set1151-375, set11-275, and 
set11-250 were generated and immunoprecipitation assay was performed as described in 
Figure 2.1C. To our surprise, none of these Set1 truncations bind to RNAPII containing 
Ser5-P CTD (Figure 2.2F). The RRM1 domain localizes at amino acids 230-335, and 
both set1151-375 and set1211-1080 contain RRM1 and do not interact with RNAPII. 
Together, these data indicate that RRM1 cannot interact with RNAPII by itself and both 
RRM1 domain and the uncharacterized region upstream of RRM1 are required for Set1-
RNAPII interaction. 
Since amino acids 102-151 of Set1 is in uncharacterized region (upstream of 
RRM1), we performed BLAST analysis of this region and identified two conserved sites: 
RP (amino acids 133, 134) and KFHYFD (amino acids 148-153) (Figure 2.3A). 
Interestingly, all the identified proteins are Set1 orthologues in different genera under the 
same family of Saccharomycetaceae (Figure 2.3A), however, these sites cannot be 
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identified in a different family or in other higher eukaryotes, however, there might be 
some very distant conservation. To test whether these two sites are required for Set1 and 
RNAPII interaction, we generated CEN plasmids containing 3×FLAG tagged Set1 and 
set1 point mutants in the conserved region, and all Set1 and set1 mutants were expressed 
from a SET1 promoter. Then, the indicated vectors were transformed to the RPB3-3×HA, 
set1∆ strain. The whole cell extracts of indicated strains were prepared and subjected to 
α-FLAG (M2) immunoprecipitation and analyzed by Western blot using α-Ser5P (H14), 
α-FLAG (M2), and α-HA (12CA5) antibodies. As shown in Figure 2.3B, the Set1-Ser5-
P-CTD interaction and Set1-Rpb3 interaction are disrupted by mutants in conserved sites 
(RPAA, RE, YFDAAA, and ∆(KFHYFD)), and the interactions are not disrupted 
by mutation in the non-conserved sites (SA at 136 a.a.). Moreover, the disruptions of 
the Set1-RNAPII interaction are at different degrees in mutants from two sites: the Set1 
RP site mutants (RPAA and RE) still interact with RNAPII at a low level, while the 
interactions between RNAPII and Set1 KFHYFD site mutants (YFDAAA and 
∆(KFHYFD)) are below the detection of Western blot. Together, we termed Set1 amino 
acids 133-153 as Set1 RNA polymerase II interacting motif (SRIM), which is required 
for Set1-RNAPII interaction. However, this SRIM does not share homology with the SRI 
domain of Set2 or any other CTD binding proteins in S. cerevisiae.  
Previously studies suggested that yeast Swd2 interacts with amino acids 1-229 of 
Set1 in vitro, and human Wdr82 (Swd2 homolog) is required for human Setd1A to 
interact with Ser5-P CTD peptides in vitro (115, 117). Thus, it is possible that the Set1 
SRIM mutants could disrupt the interaction between Set1 and Swd2. To test this 
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possibility, vectors expressing Set1 and set1 SRIM mutants were transformed to SWD2-
3×HA, set1∆ stain, and an immunoprecipitation assay was performed as described in 
Figure 2.3B. As shown in Figure 2.3C, Swd2 interacts with all the Set1 SRIM mutants, 
that disrupted the Set1-RNAPII interaction, suggesting that SRIM of Set1 is not required 
for Set1 interacting with Swd2.  
To determine whether Set1 specifically interacts with the phosphorylation of Ser5 
on CTD, not other domains of Rpb1 or other RNAPII subunits, we generated pRS415-
PYK1p-NLS-GST-CTD fusion constructs, including GST tagged full-length wild-type 
CTD, GST tagged S2A CTD (all Ser2 mutated to Ala in 26 repeats), or GST tagged S5A 
CTD (all Ser5 mutated to Ala in 26 repeats). These vectors were transformed to wild-
type, SET2-3×FLAG, and 3×FLAG-SET1 strains. The whole cell extracts of indicated 
strains were prepared and subjected to an α-FLAG (M2) immunoprecipitation assay and 
followed by Western blot using α-FLAG (M2), α-Ser5P (3E8), and α- Ser2P (H5) 
antibodies. As shown in Figure 2.4A, the blots for inputs show the presence of Ser5-P in 
wild-type CTD and S2A CTD, not in S5A CTD, and the result shows Set1 interacts with 
wild-type CTD and S2A CTD, not S5A CTD. To further determine whether set1 SRIM is 
required for this interaction, the pRS415-PYK1p-NLS-GST-CTD vector was transformed 
to the set1∆ strain with full length Set1 or set1 YFDAAA mutant expressed from 
pRS416. As shown in Figure 2.4B, Set1 interacts with wild-type CTD while Set1 
YFDAAA mutant fails to. These results indicate that Set1 specifically interacts with 
the phosphorylation of Ser5 on CTD, and this interaction requires SRIM. 
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2.3.3 The SRIM is required for Set1 localization and H3K4 trimethylation levels at 5’ 
of actively transcribed gene 
Given the Set1 and RNAPII interaction is potentially important for Set1 function, 
we sought to investigate the consequences of Set1 SRIM mutants in yeast. To determine 
whether the set1 SRIM mutants cause a loss of global H3K4 methylation, the whole cell 
extracts of indicated strains were blotted with antibodies specifically against H3K4 
mono-, di-, and trimethylation. With H3 levels as the loading controls, the results showed 
that set1 mutants have distinct global levels of H3K4 trimethylation: set1 YFDAAA 
mutant has a great reduction in global H3K4 trimethylation level, whereas the RE 
mutant has a slightly decrease or no change in global H3K4 trimethylation level 
comparing to wild-type SET1 strain (Figure 2.5A). The difference may be due to set1 
RE mutant partially disrupt Set1-RNAPII interaction (Figure 2.3B and C) Interestingly, 
the global mono- and dimethylation levels of the set1 SRIM mutants are not changed 
compared to wild-type SET1 strain (Figure 2.5A). The decrease of global H3K4 
trimethylation is not due to loss of Set1 protein, for the Set1 protein levels of different 
mutants do not show difference with Set1 (Figure 2.5A).  
To determine whether Set1 SRIM mutants disrupt Set1 localization at actively 
transcribed genes, an α-FLAG (M2) ChIP analysis was performed using the indicated 
stains. As shown in Figure 2.5C, the wild-type Set1 is predominantly enriched at 5’ over 
promoters and 3’ of PYK1 gene compared to untagged wild-type background; whereas 
set1 SRIM (RE and YFDAAA) mutants are no longer significantly enriched at 5’ 
over promoters and 3’ of PYK1 gene (Figure 2.5C). Our data indicates that the Set1-
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RNAPII interaction is required for Set1 association with 5’ of active gene. Then we 
sought out to determine whether the set1 SRIM mutants affect H3K4 methylation 
deposition by ChIP assay using histone specific antibodies. As shown in Figure 2.5D, 
The H3K4 trimethylation distribution in set1 YFDAAA mutant is overall greatly 
decreased on promoter, 5’ and 3’ of PYK1 gene, however the H3K4 trimethylation in set1 
RE mutant shares a similar level with Set1. This is correlated with the global H3K4 
trimethylation levels in Figure 2.5A. The difference may be also due to set1 RE mutant 
partially disrupt Set1-RNAPII interaction (Figure 2.3B and C) As for H3K4 
dimethylation, both set1 SRIM mutants shows no significant change compared to wild-
type Set1. Besides PYK1 gene, we also performed the ChIP analysis on another active 
gene, PMA1, which shows similar results as PYK1 gene (Figure 2.5F, G, H, and I). 
Together, because set1 RE mutant still partially interacts with RNAPII, we conclude 
that Set1-RNAPII is required for proper Set1 association with 5’ of active gene and the 
deposition of H3K4 trimethylation at 5’ of active gene, while the H3K4 dimethylation of 
active gene is not dependent by Set1-RNAPII interaction. 
2.3.4 Set1 SRIM mutants disrupt Set1 recruitment and H3K4me3 at the 5’ of the 
induced PCK1 gene. 
To further investigate whether Set1 SRIM mutants affect Set1 recruitment and 
H3K4 methylation deposition, we looked in yeast gene at inducible condition. When the 
carbon souse of yeast medium is switched from glucose to acetate, the gluconeogenesis 
pathway will be turned on and the transcript levels of Phosphoenolpyruvate 
carboxykinase (PCK1) gene is quickly increased in both wild-type and set1∆ (Figure 
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2.6A). The Set1 protein levels and global H3K4 trimethylation remain unchanged under 
acetate condition for tested 4 hours (Figure 2.6B). The 3×FLAG-Set1 is increasingly 
recruited to the promoter and 5’ of PCK1 gene from 0 to 2 hours (Figure 2.6D) And 
H3K4 trimethylation is increasingly enriched at promoter and 5’ of PCK1 gene from 0 to 
4 hours (Figure 2.6F).  
To determine whether the PCK1 transcription will be affected by set1 SRIM 
mutants, the transcript levels of PCK1 in set1 mutants under inducible condition were 
determined by qRT-PCR (Figure 2.7A). The statistical analysis shows there is no 
significant difference between set1 mutants with Set1 when PCK1 is turned on for 4 
hours. In addition, the Set1 protein levels in Set1 and set1 mutants remain unchanged for 
tested 2 hours (Figure 2.7B). And the global levels of H3K4 mono-, di- and 
trimethylation in different mutants are not changed from their original levels during the 
medium switch for 2 hours (Figure 2.7B). 
Interestingly, as shown in Figure 2.8A and C and compared to full-length Set1, 
set1 SRIM mutants (RE and YFDAAA) fail to be recruited at promoter and 5’ of 
PCK1 gene and in these two mutants the H3K4 trimethylation are failed to be enriched at 
PCK1 gene when PCK1 gene is turned on. The PCK1 is turned on normally as there is no 
defect of Rpb3 recruitment on PCK1 gene (Figure 2.7A and 2.8B). This suggests the role 
of RNAPII in recruiting Set1 to deposit H3K4 trimethylation at the gene when the gene is 
turned on. However, the function of the H3K4 trimethylation is still unknown. 
As shown in Figure 2.8D, set1 YFDAAA mutant fails to establish H3K4me2 
and set1 RE mutant has a delay to establish H3K4me2 at promoter and 5’ ends of 
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PCK1 gene for tested 2 hours when PCK1 gene is turned on. This suggests the role of 
RNAPII in recruiting Set1 to deposit H3K4 dimethylation at the gene when the gene is 
turned on.  
2.3.5 Set1 SRIM mutants have growth defect on 6-AU  
6-azouracil (6-AU) is a drug that decreases the intracellular GTP and UTP pools, 
resulting in yeast growth sensitivity when there is a defect in transcriptional elongation. 
Based on studies that the deletion of SET1 or H3K4R mutant showed growth defects on 6-
azouracil (6-AU) and Set1 SRIM mutants affect Set1 recruitment and H3K4 trimethylation 
deposition, we sought to determine whether Set1 SRIM mutants have growth defects on 6-
AU (111). As shown in Figure 2.9A, set1∆ with vector has a slow growth defect on 150 
μg/ml 6-AU plates at 30°C, and this defect is more severe when the plate is placed at 37°C. 
The full length Set1 expressed from CEN vector can rescue this growth defect at both 
temperatures, while Set1 H1017K catalytic mutant cannot. However, the Set1 RE and 
YFDAAA mutant still have growth defects on 6-AU, more severely at 37°C. 
Interestingly, the Set1 RE mutant grew a better than YFDAAA mutant, which is 
correlated with the global H3K4 trimethylation level of Set1 RE mutant is higher than 
YFDAAA mutant.  
2.3.6 Overexpression of set11-375 exhibits slow growth phenotype 
As shown in Figure 2.2A, set11-375 is necessary and sufficient to interact with 
RNAPII. It is possible that overexpression this domain results in a gain of function to 
compete with endogenous Set1 binding to RNAPII. Thus, we generated pRS425-PYK1p-
set1(1-375) and pRS425-PYK1p-set1(1-375) YFDAAA mutant and transformed them 
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into wild-type and set1Δ strain. Overexpression of set11-375 exhibits a slightly slow 
growth phenotype in both wild-type and set1Δ strain, and overexpression of set11-375 
YFDAAA mutant does not show this slow growth phenotype. This indicates the slow 
growth phenotype is independent of endogenous Set1 and it is possible that the slow 
growth phenotype is through set11-375 competing with other important proteins for Ser5-P 
CTD of RNAPII. 
 
 Discussion 
2.4.1 Identification and characterization of how Set1 interacts with RNAPII containing 
Ser5-P CTD. 
In this study, we determined that Set1 interacts Ser5-P and/or Ser7-P CTD of 
RNAPII, whereas Set2 binds to Ser2-P, Ser5-P, and/or Ser7-P CTD of RNAPII. It 
suggests that besides Ser2-P and Ser5-P, the phosphorylation on Ser7 in CTD also plays a 
role in recruiting histone methyltransferases. In addition, we determined that Set1-
RNAPII interaction is independent of Paf1 complex and most Set1-associated subunits. 
This contradicts with the current model that RNAPII recruitment of Set1 is mediated by 
Paf1 complex (150-152). However, in these previous studies, it is determined the 
dependency of paf1 complex in Bre2-RNAPII interaction (150, 151). As shown in Figure 
2.1C, Set1-RNAPII interaction is independent of Bre2. Our data is supported by the study 
that Setd1A, Set1 homolog in human, fails to be co-immunoprecipitated with Paf1 (117).  
We also determined the SRIM of Set1 and requirement of SRIM for Set1-RNAPII 
interaction. The unique feature of this motif is that SRIM mutants only disrupt Set1-
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RNAPII interaction without disrupting Set1-Swd2 interaction. The study of interactions 
between Set1 and Set1-associated subunits shows that only Swd2 binds to N terminus of 
Set1 (amino acids 1-229) and all the other Set1 complex subunits associate with 
downstream of that region (115). Thus, the SRIM mutants provide valuable tools to study 
the Set1 function independent of RNAPII recruitment with all Set1-assoicated subunits 
on board.  
By protein sequence comparison, the human RRM domain in Setd1A exhibits 
23% identity and 42% similarity to yeast Set1 RRM1 domain, however, the SRIM cannot 
be identified in Setd1A, suggesting the Set1 proteins are quite divergently evolved. The 
human Setd1A RRM and Ser5-P CTD interaction is dependent of Wdr82 in vitro (117). 
In our study, we did not rule out the possibility that Swd2 is required for Set1-RNAPII 
interaction, however, our data shows that without Set1, Swd2 does not bind to RNAPII. 
Because Swd2 also functions in the cleavage and polyadenylation factor complex which 
is essential for yeast, and the deletion of SWD2 can be achieved by overexpression C-
terminus of Sen1 (164). To determine whether Swd2 is required for Set1-RNAPII 
interaction, immunoprecipitation assay of Set1 with RNAII in deletion strain of SWD2 
and overexpression C-terminus of Sen1 and in vitro binding assay of Set1, Swd2, and 
Ser5-P CTD are needed in future.  
2.4.2 Characterization the dependency of RNAII in Set1 recruitment and Histone H3K4 
methylation deposition 
Our set1 SRIM mutants show a great reduction of Set1-chromatin association at 
5’ without affecting set1 mutant localization at promoter and 3’ of actively transcribed 
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genes (Figure 2.5C), and set1 SRIM mutants fail to be recruited by RNAPII at induced 
PCK1 gene. This is, for the first time, the direct evidence to support the model that Set1 
is recruited by RNAPII containing Ser5-P CTD at 5’ of active genes. However, the 
previous model is not complete: without RNAPII recruitment, set1 SRIM mutants are 
still enriched and evenly distributed at promoter, 5’, and 3’ of actively transcribed genes 
over the background, possibly revealing an unknown mechanism of Set1 recruitment to 
chromatin independent of RNAPII.  
Our data also suggest that Set1 can be recruited to chromatin to deposit H3K4 
trimethylation at transcription start site through a RNAII recruitment manner, as set1 
YFDAAA mutant has a great decrease in H3K4 trimethylation levels globally and gene 
specifically (Figure 2.10). Interestingly, the set1 RE mutant, with partial disruption in 
Set1-chromatin association, has full levels of H3K4 trimethylation globally and at active 
gene. This could be explained by the RE mutant still interacts with RNAPII containing 
Ser5-P at low level. It is possible that this weak interaction is enough to establish full 
trimethylation at actively transcribed genes in steady state and this transient and weak 
set1 mutant and chromatin interaction cannot be detected by ChIP.  
Our combined data suggest that Set1 can also be recruited to chromatin and 
methylate H3K4 through other mechanisms independent of RNAII recruitment (Figure 
2.10). This idea can be support by multiple studies from us and other labs that the C-
terminus of Set1, containing nSET domain, SET domain, and post-SET domains, has full 
levels of mono- and dimethylation, and partial trimethylation activity in vivo (113, 115, 
116). As shown in Figure 2.2B, C-terminus of Set1, containing amino acids 690-1080, 
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does not interacts with RNAPII. The RNAPII-independent Set1 recruitment could be 
through Set1-asscoiated subunits or other unknown mechanisms. Our previous data 
showed, set2 without SRI domain still binds to nucleosome and catalyze H3K36 
monomethylation (165). 
Interestingly, in set1 YFDAAA mutant, H3K4 trimethylation is reduced overall 
across the ORF, however, it is still more enriched at 5’ comparing to promoter and 3’ 
ends, while Set1 is enriched evenly at promoter, 5’ and 3’ of ORF. The enrichment of 
H3K4 trimethylation at 5’ of ORF in the YFDAAA mutant is independent of Set1 
occupancy and interaction between Set1 and RNAPII. The mechanism for this is still 
unknown. One possibility is that Set1 catalytic activity is activated at 5’ due to 
stimulation by other factors. Another possibility is that the turnover speeds of H3K4 
trimethylation marker are faster at promoter and 3’ than 5’ ends of ORF. By disrupting 
Set1-RNAPII interaction results in decrease of overall H3K4 trimethylation but H3K4 
trimethylation is still enriched at 5’ ends of ORF. 
The 6-AU assay suggested there are potential transcriptional defects in set1 SRIM 
mutants. Further experiments would be needed to show transcriptional elongation is 
reduced, for example nuclear run-on assay. 
 
 Materials and Methods 
 
Yeast strains and strain construction 
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All yeast strains were derived from S. cerevisiae BY4741 (MATa his3∆1 leu2∆0 
met15∆0 ura3∆0) or BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0). Genotypes of all 
strains used in this study are described in Table 2.2. The 3×FLAG-SET1 was generated 
by using pK3F as template in BY4741. C-terminal 3×FLAG tagged Bre2, Swd1, Spp1, 
Swd2, Swd3, Sdc1, and Shg1 strains using p3FLAG vector (166). The bre2∆, swd1∆, 
swd3∆, spp1∆, sdc1∆, shg1∆, paf1∆, ctr9∆, cdc73∆, rtf1∆, and leo1∆ in 3×FLAG-SET1 
were generated by PCR mediated gene amplified the KanMX cassette from 
Saccharomyces genome deletion project (167). A deletion allele of SET1 is generated by 
PCR amplification of HphMX cassette from pAG32 (168). 
Preparation of yeast whole-cell extracts, Western blot analysis and antibodies 
Yeast extracts and Western blot analysis were performed as described previously (113, 
119, 169). The α-FLAG (M2) mouse antibody (Sigma, F1804) was used at 1:5,000. The 
α-FLAG rabbit antibody (Sigma, F7425) was used at 1:5,000. The glucose-6-phoshate 
dehydrogenase rabbit antibody (Sigma, A9521) was used at 1:50,000. The α-H3K36me3 
rabbit antibody (Abcam, Ab9050) was used at 1:5,000. The α-H3 rabbit antibody (Active 
Motif, 39163) was used at 1:5,000. The α-H3K4me3 rabbit antibody (Active Motif, 
39159) was used at 1:100,000. 4E12 antibody (specific to P-Ser7 CTD, Emdmillipore, 
04-1570) was used 1:5,000, H14 antibody (specific to Ser5P CTD, Covance, MMS-
134R) was used at 1: 10,000. H5 antibody (specific to P-Ser2 CTD, Covance, MMS-
129R) were used at 1:2,000 for IP and 1:10,000 for input. 3E8 (α-Ser5P, Emdmillipore, 
04-1572) was used 1:5,000. 
Gene expression analysis 
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RNA transcript levels were determined using quantitative real-time PCR (qRT-PCR) as 
previously described (133). Three technical repeats were performed for each of the three 
biological repeats. The All CT values were analyzed by normalizing values to ACT1 
or MDH3 and transcript levels of SET1 were compared relative to the transcript level in a 
WT strain. The primer sequences used can be found in Table 2.1.  
Immunoprecipitation assay 
The overnight cultures of indicated yeast cells were diluted to an OD600 of 0.01 and 
regrew up to an OD600 of 0.6-0.8, 100 mL cultures were harvested, and quickly followed 
by whole-cell extracts by beads beating in by using lysis Buffer (20mM HEPES pH8.0, 
350mM NaCl, 10% glycerol, 0.1% Tween 20, with freshly added 1µl/ml pepstatin (1 
mg/ml), 1 µl/ml Aprotinin/ leupeptin (1 mg/ml), 1 µl/ml PMSF (100mM), 20mM Sodium 
fluoride, and 20mM sodium orthovanadate). 2 µl α-FLAG (M2) monoclonal antibody 
(Sigma F1804) was conjugated to 10 μl Protein-G magnetic beads (Dynabeads, Life 
Technologies 10004D) for about 30 min. The extracts were incubated with pre-
equilibrated α-FLAG (M2) conjugated magnetic beads for 2 h at 4°C, then the beads were 
washed three times with 1ml of lysis Buffer containing protease and phosphatase 
inhibitors mentioned above for 5 min each. The beads were boiled in SDS-PAGE loading 
buffer, and bead-bound proteins were separated by a magnet and analyzed by 
immunoblotting with antibodies directed against the phosphorylated CTD and α-FLAG 




For normal glucose cell grow condition, the condition is same as immunoprecipitation 
assay. For acetate inducible condition, all strains were grown overnight to saturation in 
SC-Ura media. They were then back diluted to OD600 0.01 in 100 ml SC-Ura media and 
grown at 30°C to mid-log phase (OD600 0.6), the cells were suspended and washed once 
with SC-Ura with 1% potassium acetate (no glucose). Then the cells were regrown in 100 
ml SC-Ura with 1% potassium acetate for indicated time. The ChIP assay procedure was 
ZipChIP method as described previously (170). The primer sequences are in Table 2.1. 
6AU growth assay 
Indicated yeast strains were grown in synthetic complete drop-out media lacking uracil 
(SC-Ura). Overnight cultures were diluted to an OD600 of 0.1 and regrown to an OD600 
of 0.6, and fivefold serial dilutions were plated on SC-Ura plates with or without 6-AU 
(Sigma) at final concentration of 150 µg/ml. Cells were grown at 30°C and 37°C before 
plates were photographed.  
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Table 2.2 Yeast Strains and Genotype in Chapter 2 
Yeast Strain Genotype Reference 
BY4741 (wild-
type) 
MATa his3 leu20 LYS2 met150 ura30 
Open 
Biosystems 
Set2-3×FLAG BY4742 SET2-3×FLAG::KanMX (141) 
Set2-
(SRI)3×FLAG 
BY4742 SET21-618-3×FLAG::KanMX (141) 
SDBY1420  BY4741 set1∆::HphMX This study 
SDBY1421 BY4741 SET1::loxP-3×FLAG-SET1 This study 





SDBY1503 BY4741 SWD1::SWD1-3×FLAG This study 
SDBY1504 
BY4741 SWD1:: SWD1-3×FLAG, 
set1∆::HphMX 
This study 
SDBY1505 BY4741 SPP1:: SPP1-3×FLAG This study 
SDBY1506 
BY4741 SPP1:: SPP1-3×FLAG, 
set1∆::HphMX 
This study 
SDBY1507 BY4741 SWD2:: SWD2-3×FLAG This study 
SDBY1508 
BY4741 SWD2:: SWD2-3×FLAG, 
set1∆::HphMX 
This study 
SDBY1509 BY4741 SWD3:: SWD3-3×FLAG This study 
SDBY1510 
BY4741 SWD3:: SWD3-3×FLAG, 
set1∆::HphMX 
This study 
SDBY1511 BY4741 SDC1:: SDC1-3×FLAG This study 
SDBY1512 
BY4741 SDC1:: SDC1-3×FLAG, 
set1∆::HphMX 
This study 
SDBY1513 BY4741 SHG1:: SHG1-3×FLAG This study 
SDBY1514 




























Table 2.2 continued 
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SDBY1525 BY4741 RPB3::RPB3-3HA, set1∆::HphMX  This study 




Figure 2.1 Set1 interacts with RNAPII containing Ser5-P and Ser7-P CTD, and 




(A) Immunoprecipitation assay shows that Set1 interacts with RNAPII containing 
Ser5-P and/or Ser7-P CTD. FLAG tagged Set1, Set2, and set2(∆SRI) are expressed 
from their endogenous promoters. Whole cell extracts were prepared and subjected to 
α-FLAG (M2) immunoprecipitation and followed by Western blotting using antibodies 
specific to Serine phosphorylated CTD (α-Ser5P (H14), α-Ser2P (H5), and α-Ser7P 
(4E12)) and M2 α-FLAG antibody. Set2-3×FLAG was used as a positive control, and 
WT and set2(∆SRI)-3×FLAG were used as negative controls. The whole cell lysates 
were blotted with α-Ser5P, α-Ser2P and α-Ser7P for input levels. (B) 
Immunoprecipitation assay shows that Set1 is required for the interactions between 
Set1 complex subunits and RNAPII. C-terminal 3×FLAG tagged BRE2, SWD1, SPP1, 
SWD2, SWD3, SDC1, and SHG1 strains were generated in WT and set1∆ strains. 
Whole cell extracts were prepared and subjected to α-FLAG (M2) immunoprecipitation 
and followed by Western blot using α-Ser5P (H14) and rabbit α-FLAG antibodies. 
Set2-3×FLAG was used as a positive control, and set2(∆SRI)-3×FLAG were used as 
negative control. The whole cell lysates were blotted with α-Ser5P for input levels. The 
double bands of CTD of RNAPII is due to different phosphorylation levels of RNAPII. 
(C) Immunoprecipitation assay shows that Set1-RNAPII interaction is independent of 
most Set1 complex subunits. The Set1 complex subunits deletion strains bre2∆, swd1∆, 
swd3∆, spp1∆, sdc1∆, and shg1∆ were generated in 3×FLAG-SET1 strain. Whole cell 
extracts were prepared and subjected to α-FLAG (M2) immunoprecipitation and 
followed by Western blotting using α-Ser5P (H14) M2 α-FLAG antibodies. WT was 
used as a negative control. The whole cell lysates were blotted with α-Ser5P for input 
levels. (D) Immunoprecipitation assay shows that Set1-RNAPII interaction is 
independent of Paf1 complex. The individual deletion of Paf1 complex subunits paf1∆, 
ctr9∆, cdc73∆, rtf1∆, and leo1∆ were generated in 3×FLAG-SET1 strain. Whole cell 
extracts were prepared and subjected to α-FLAG (M2) immunoprecipitation and 
followed by Western blotting using α-Ser5P (H14) M2 α-FLAG antibodies. WT was 
used as a negative control. The whole cell lysates were blotted with α-Ser5P for input 
levels. (E) Deletions of individual Paf1 complex subunits affect global H2B 
monoubiquitination and H3K4 methylation. Yeast whole cell extracts of indicated 
strains were blotted for H2B K123ub and methyl specific antibodies for H3K4 







Figure 2.2 Identification of a novel region in Set1 required for RNAPII 
interaction. 
(A) Schematic representation of the Set1 constructs used to determine the Set1-
RNAPII interacting region. The domain structure of Set1 contains two RNA 
recognition motifs (RRM1 and RRM2), an n-SET domain, a SET domain, and a post-
SET domain. (B) Immunoprecipitation assay shows that Set11-375 is necessary and 
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sufficient to interact with RNAPII containing Ser5-P CTD. 3×FLAG tagged Set1 and 
indicated set1 truncations were expressed from CEN plasmids under SET1 promoter. 
The whole cell extracts were prepared and subjected to α-FLAG (M2) 
immunoprecipitation assay and followed by Western blotting using α-Ser5P(H14) and 
rabbit α-FLAG antibodies. The set1Δ with vector was used as negative control and the 
whole cell lysates were blotted with α-Ser5P for input levels. (C) Schematic 
representation of Set1 N-terminal sequential truncation constructs used to further 
determine the Set1-RNAPII interacting region. (D) Immunoprecipitation assay shows 
that Set1 amino acids 102-150 are required for interacting with RNAPII containing 
Ser5-P CTD. Set1 and set1 truncations are expressed under SET1 promoter from CEN 
plasmids. The immunoprecipitation assay was performed as described in Figure 2.2B. 
WT with vector was used as negative control and the whole cell lysates were blotted 
with α-Ser5P for input levels. (E) Schematic representation of Set1 truncation 
constructs used to further determine the Set1-RNAPII interacting region. (F) 
Immunoprecipitation assay shows that both RRM1 and the uncharacterized region 
upstream of RRM1 are required for Set1-RNAPII interaction. 3×FLAG tagged set1 
truncations were expressed under PYK1 promoter from 2 micron plasmids. The 
immunoprecipitation assay was performed as described in Figure 2.2B. The set1Δ with 
vector was used as negative control and the whole cell lysates were blotted with α-









Figure 2.3 Conserved Set1 N-terminal residues are required for the Set1 
interaction with the Ser5-P CTD of RNAPII. 
(A) Sequence alignment of N-terminal uncharacterized regions of Set1 and its 
homologs from Saccharomycetaceae family. Sequences were aligned using Clustal 
Omega. An asterisk (*) indicates the position has a fully conserved residue; and a colon 
(:) indicates the position has high similarity between different groups. The most 
conserved residues in SRIM were bold. (B) Co-immunoprecipitation assay shows Set1 
mutants in RP and KFHYFD sites disrupt Set1-RNAPII interaction. The constructs 
containing Set1 or indicated set1 mutant were transformed to RPB3-3×HA, set1∆ 
strain. The whole cell extracts were prepared and subjected to α-FLAG (M2) 
immunoprecipitation assay and followed by Western blot using antibodies α-HA 
(12CA5) for Rpb3, α-Ser5P (H14) for CTD of RNAPII, M2 α-FLAG for Set1. WT 
with vector was used as a negative control and the whole cell lysates were blotted with 
α-Ser5P and α-HA for input levels. (C) Co-immunoprecipitation assay shows set1 
SRIM mutants still interact with Swd2. The constructs containing Set1 or indicated 
set1 mutant were transformed to SWD2-3×HA, set1∆ strain. The immunoprecipitation 
assay was performed as described in Figure 2.3B using antibodies α-HA (12CA5) for 
Swd2, α-Ser5P (H14) for CTD of RNAPII, M2 α-FLAG for Set1. WT with vector was 
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used as a negative control and the whole cell lysates were blotted with α-Ser5P and α-





Figure 2.4 Set1 interacts with the phosphorylation of Ser5 on CTD repeats in vivo. 
(A) Co-immunoprecipitation assay shows Set1 specifically interacts with the 
phosphorylation of Ser5 on CTD repeats. The PYK1p-NLS-GST-CTD fusion 
constructs containing wild-type, S2A, or S5A CTD repeats were transformed to 
indicated strains. The whole cell extracts were prepared and subjected to α-FLAG (M2) 
immunoprecipitation assay and followed by Western blot using α-Ser5P(3E8), α-
Ser2P(H5), and M2 α-FLAG antibodies. The wild-type with vector was used as a 
negative control and the whole cell lysates were blotted with α-Ser5P and α-Ser2P for 
input levels. (B) Co-immunoprecipitation assay shows set1 SRIM mutant disrupts Set1 
interacting with the phosphorylation of Ser5 on CTD repeats. FLAG 
immunoprecipitations were blotted using α-Ser5P, α-Ser2P, and M2 FLAG. The WT 
with vector was used as a negative control and the whole cell lysates were blotted with 
α-Ser5P, α-Ser2P, and α-GST for input levels. The immunoprecipitation assay of 
indicated strains was performed as described in Figure 2.4A. The wild-type with vector 
was used as a negative control and the whole cell lysates were blotted with α-Ser5P, α-









Figure 2.5 The SRIM is required for Set1 localization and H3K4 trimethylation 
levels at 5’ of actively transcribed gene 
(A) Set1 protein levels are not changed in set1 SRIM mutants. Yeast whole cell 
extracts of indicated strains were blotted for α-FLAG (M2) for Set1 protein level, and 
methyl specific antibodies for H3K4 methylation status, α-H3 and α-G6PDH for 
loading control. (B) Schematic of regions analyzed for ChIP using specific primers 
across the PYK1 gene. (C) ChIP analysis of 3×FLAG tagged Set1 and set1 SRIM 
mutants was performed using M2 α-FLAG antibody, and the signal is normalized to 
input and relative to WT. (D) ChIP analysis of 3×FLAG-SET1 and set1 SRIM mutants 
was performed using α-H3K4me3 antibodies, respectively, and the signal is 
normalized to H3 and input levels, then relative to the signal of set1Δ strain. Three 
technical repeats were performed for each of the three biological repeats in all ChIP 
analysis in Figure 2.5 and the error bars represent the standard error of the mean. (E) 
ChIP analysis of 3×FLAG-SET1 and set1 SRIM mutants was performed using α-
H3K4me2 antibodies, respectively, and the signal is normalized to H3 and input levels, 
then relative to the signal of set1Δ strain. Three technical repeats were performed for 
each of the three biological repeats in all ChIP analysis in Figure 2.5 and the error bars 
represent the standard error of the mean. (F) Schematic of regions analyzed for ChIP 
using specific primers across the PMA1 gene. (G) ChIP analysis of 3×FLAG tagged 
Set1 and set1 SRIM mutants was performed using M2 α-FLAG antibody, and the 
signal is normalized to input and relative to WT. (H) ChIP analysis of 3×FLAG-SET1 
and set1 SRIM mutants was performed using α-H3K4me3 antibodies, respectively, and 
the signal is normalized to H3 and input levels, then relative to the signal of set1Δ 
strain. Three technical repeats were performed for each of the three biological repeats 
in all ChIP analysis in Figure 2.5 and the error bars represent the standard error of the 
mean. (I) ChIP analysis of 3×FLAG-SET1 and set1 SRIM mutants was performed 
using α-H3K4me2 antibodies, respectively, and the signal is normalized to H3 and 
input levels, then relative to the signal of set1Δ strain. Three technical repeats were 
performed for each of the three biological repeats in all ChIP analysis in Figure 2.5 and 




Figure 2.6 Set1 is recruited to the PCK1 gene to deposit H3K4 trimethylation after 
the switch of yeast growth media from glucose to acetate. 
(A) The transcript levels of PCK1 is increasing in both WT and set1Δ strain after yeast 
media switched from glucose to acetate. The relative transcript levels of PCK1 are 
determined by qRT-PCR analysis. Indicated yeast strain was collected before the 
switch and 0.5, 1, 2 and 4 hours after the switch from SC glucose to SC acetate. Data 
was normalized to transcript levels of MDH3 and relative to untagged WT collected 
before the media switch. (B) The global Set1 protein levels and global H3K4 
trimethylation is not changed after yeast media switched from glucose to acetate for 4 
hours. Indicated yeast strain was collected before the switch and 1, 2 and 4 hours after 
the switch from SC containing glucose to SC containing acetate, and the whole cell 
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extracts were analyzed by Western blot using M2 α-FLAG and α-H3K4me3 
antibodies. The whole cell lysates were blotted with α-H3 for input levels. (C) 
Schematic of regions analyzed for ChIP using specific primers across the PCK1 gene. 
(D) ChIP analysis of 3×FLAG tagged Set1 was performed using M2 α-FLAG 
antibody, and the signal is normalized to input and relative to WT. Sample collection is 
same with Figure 2.6B. (E) ChIP analysis of Rpb3 recruitment on PCK1 gene was 
performed using α-Rpb3 antibody. The signal is normalized to input and relative to 
WT with beads with no antibody. Sample collection is same with Figure 2.6B. (F) 
ChIP analysis of 3×FLAG-SET1 strain was performed using α-H3K4me3 antibody, 
and the signal is normalized to H3 and input levels, then relative to the signal of set1Δ 
strain. Sample collection is same with Figure 2.6B. Three technical repeats were 
performed for each of the three biological repeats in all ChIP and Gene expression 







Figure 2.7 The set1 mutants do not affect transcript levels of PCK1 and the Set1 
protein levels and global H3K4 methylation levels are not changed after the 
switch of yeast growth media from glucose to acetate. 
(A) The transcript levels of PCK1 is increasing in set1 mutants when yeast growth media 
switched from glucose to acetate. The relative transcript levels of PCK1 are determined 
by qRT-PCR analysis. Sample collection is same with Figure 2.6B and the media used is 
SC-Ura. Data was normalized to MDH3 and relative to untagged WT collected at time 0 
hour. Three technical repeats were performed for each of the three biological repeats and 
the error bars represent the standard error of the mean. (B) The global Set1 protein levels 
and global H3K4 mono-, di-, and trimethylation levels of Set1 and set1 mutants were 
determined after yeast growth media switching form glucose to acetate for 2 hours. 
Sample collection is same with Figure 2.7A. The whole cell extracts were analyzed by 
Western blot using M2 α-FLAG, α-H3K4me1, α-H3K4me2, and α-H3K4me3 antibodies. 






Figure 2.8 The SRIM is required for Set1 recruitment by RNAPII and H3K4 
trimethylation establishment at 5’ of induced PCK1 gene  
(A) ChIP analysis of 3×FLAG tagged Set1 recruitment on PCK1 gene in indicated set1 
mutants was performed using M2 α-FLAG antibody, and the signal is normalized to 
input and relative to WT. Indicated yeast strain was collected at before the switch and 1 
and 2 hours after the switch of media from SC-Ura to SC-Ura acetate. (B) ChIP 
analysis of Rpb3 recruitment on PCK1 gene in indicated set1 mutants was performed 
using α-Rpb3 antibody. The signal is normalized to input and relative to WT with 
beads but no antibody. Sample collection is same with Figure 2.7A. (C) ChIP analysis 
of H3K4 trimethylation establishment on PCK1 gene in indicated set1 mutants was 
performed using α-H3K4me3 antibody, and the signal is normalized to H3 and input 
levels, then relative to the signal of set1Δ strain. Sample collection is same with Figure 
2.7A. Three technical repeats were performed for each of the three biological repeats in 
all ChIP analysis in Figure 2.8 and the error bars represent the standard error of the 
mean. (D) ChIP analysis of H3K4 dimethylation establishment on PCK1 gene in 
indicated set1 mutants was performed using α-H3K4me2 antibody, and the signal is 
normalized to H3 and input levels, then relative to the signal of set1Δ strain. Sample 
collection is same with Figure 2.7A. Three technical repeats were performed for each 
of the three biological repeats in all ChIP analysis in Figure 2.8 and the error bars 






Figure 2.9 set1 SRIM mutants exhibit sensitivity on 6-AU plate and 
overexpression of set1(1-375) shows a slight grow defect 
(A) Set1 and set1 mutants were grown to log phase in SC-Ura media and spotted in 5-
fold dilutions from an OD600 0.1 on plates with or without 150 mg/L 6AU. Plates 
were grown at 30ºC and 37ºC. (B) Indicated log phase strains were spotted in 5-fold 






Figure 2.10 Working model  
Set1 can be recruited to chromatin to deposit H3K4 trimethylation at transcription start 
site through a RNAII recruitment manner. Set1 can also be recruitment to chromatin 







CHAPTER 3. N-ICE PLASMIDS FOR GENERATING N-TERMINAL 3×FLAG 
TAGGED GENES THAT ALLOW INDUCIBLE, CONSTITUTIVE, OR 
ENDOGENOUS EXPRESSION IN SACCHAROMYCES CEREVISIAE
 Declaration of collaborative work 
In this study, gene expression analysis of SET2, PKC1, and ERG11 and West 
blotting analysis of PKC1 and ERG11 were performed by Nina D. Serratore. All the other 




Saccharomyces cerevisiae (S. cerevisiae) is highly efficient in homologous 
recombination, which renders PCR-mediated gene modifications such as gene deletions 
and epitope tagging possible (171, 172). Epitope tagging of genes is one of the most 
common strategies to facilitate protein detection, purification, and localization in cells. 
PCR-mediated gene modification can integrate epitope tags at the N-terminus or C-
terminus of target genes in yeast. A plasmid containing a selection marker and the 
epitope tag of interest can be used as the template for PCR amplification of a DNA 
cassette for genomic integration (173). The PCR primer contains 45-60 additional 
nucleotides that are homologous to upstream and downstream sequences of the 
integration site in the genome. By transforming yeast with the amplified PCR cassette 
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with flanking sequences homologous to the gene of interest, the selection marker cassette 
with the epitope tag will be integrated.  
C-terminal epitope tagging is relatively easy to perform because only one 
transformation step is required (174-176). The expression levels of a C-terminal tagged 
gene is comparable to that of the endogenous untagged gene because both are expressed 
from the same promoter.  
However, C-terminal epitope tagging may not be feasible for all proteins. Some 
proteins, such as Smt3, are processed at the C-terminus, resulting in a loss of the epitope 
tag after cleavage (177). Whereas other proteins, such as the Set1 histone H3K4 
methyltransferase, a C-terminal epitope tag renders the protein nonfunctional (109, 169, 
178).  
Under these circumstances, the N-terminal epitope tagging system is needed. 
Because integrating a selection marker at the N-terminus of the target gene will disrupt 
expression, different systems have been developed. One way to avoid this problem is to 
incorporate a heterologous promoter (e.g. ADH1, CYC1, GPD, TEF, and GAL1) in 
integration cassettes upstream of the epitope tag (174). Although, the tagged protein is 
not expressed at the endogenous level and the selection marker is not removed. Another 
method is to excise the selection marker after the integration, leaving the tagged protein 
expressed from the endogenous promoter (179, 180). However, N-terminal tagging 
essential genes in haploid yeast is a problem due to the disruption of the endogenous 
promoter by the drug resistant marker.  
Many different epitopes are available in S. cerevisiae, such as 6×HA, 9×MYC, 
GFP, biotin, and TAP tag (174, 175, 179, 181-183). Multiple repeats of the HA and MYC 
66 
 
epitope tags are used for enhancing the detection of lowly expressed proteins. The FLAG 
epitope, Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys, is used because of the availability of high 
affinity and specific monoclonal antibodies that recognize the FLAG sequence. Triple 
tandem repeats of the FLAG (3×FLAG) epitope can increase sensitivity for detection and 
does not affect protein function in most cases likely due to the small overall size (184). 
The 3×FLAG epitope is widely used for protein detection in assays such as 
immunoprecipitation, immunofluorescence, and protein purification in multiple model 
systems. Currently, the N-terminal 3×FLAG epitope tagging system does not readily 
permit tagging of essential genes under endogenous expression when using haploid yeast 
(185, 186).  
In this study, we have constructed the N-ICE plasmid system for PCR-based N-
terminal 3×FLAG epitope tagging of non-essential and essential genes under the control 
an Inducible promoter (GAL1), Constitutive promoters (CYC1 or PYK1), or the 
Endogenous promoter. Our N-ICE plasmid system also provides the option of three 
different selection markers, including KanMX, HphMX, and NatMX cassettes. In addition, 
the integrated selection marker and the heterologous promoter can be excised with a 
subsequent step using Cre recombinase, leaving the target gene expressed from the 
endogenous promoter. This system can also be applied to tagging essential genes 
expressed by their endogenous promoters. We have validated the N-ICE system by N-
terminal tagging two non-essential genes (SET1 and SET2) and two essential genes 
(ERG11 and PKC1). Overall, the N-ICE plasmid system will provide valuable new tools 




In this study, the N-ICE plasmid system was generated for N-terminal 3×FLAG 
epitope tagging of non-essential and essential genes under the control of an Inducible, 
Constitutive, or Endogenous promoter. The first generation N-ICE plasmids include 
pK3F, pK3F-PYK1, pK3F-GAL1, pH3F, pH3F-PYK1, and pH3F-GAL1 (Figure 3.1 A-F 
Figure 3.2 A-F). To avoid undesired PCR amplification, sequences were designed to use 
different codons for the same amino acids to avoid repeats of DNA sequences in the 
3×FLAG epitope tag. The first construct, pK3F, was generated with a loxP-KanMX-loxP 
cassette followed by a 3×FLAG epitope sequence (Figure 3.1A). In the plasmids pK3F-
PYK1 and pK3F-GAL1, the PYK1 promoter (-811bp to -1bp) and the GAL1 promoter (-
457bp to -5bp) were inserted into the pK3F plasmid downstream of the KanMX cassette 
and upstream of the second loxP site, respectively (Figure 3.1B-C). The pH3F, pH3F-
PYK1 and pH3F-GAL1 vectors were generated by replacing the KanMX cassettes in 
pK3F, pK3F-PYK1 and pK3F-GAL1 with HphMX cassettes. The P1 and P2 sites were 
designed for PCR amplification of the integration cassette containing the 3×FLAG 
epitope tag (Figure 3.3A and B). For broader application and compatibility with previous 
N-terminal tagging systems, 8 additional second generation N-ICE plasmids were 
created. Second generation N-ICE plasmids include pK3FS, pK3FS-PYK1, pK3FS-
GAL1, pK3FS-CYC1, pH3FS, pH3FS-PYK1, pH3FS-GAL1, and pN3FS-CYC1 (Figure 
3.1G-N and Figure 3.2 G-N). All the second generation plasmids contain additional S1 
and S4 sites flanking the previous P1 and P2 sites (Figure 3.3A and B). The S1 and S4 
sites are commonly used as primer sets by other N-terminal tagging systems (174, 187). 
In order to prevent low tagging efficiency due to the replacement of an existing selection 
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marker, the terminators of the HphMX cassette and the NatMX cassette have been altered 
in the second generation N-ICE plasmids (see details in the Materials and methods 
section). In addition, the CYC1 promoter (-287bp to -1bp) was used as the heterologous 
promoter in pK3FS-CYC1 and pN3FS-CYC1, since some genes will cause lethality when 
overexpressed from a strong promoter (188, 189).  
The N-ICE strategy for PCR epitope tagging is presented in Figure 3.3A and 
described in the methods. Briefly, the tagging cassettes are PCR amplified from plasmid 
templates using primers containing sequences homologous to the targeted gene. 
Depending on the construct used, the 3×FLAG-tagged genes will be expressed from a 
strong constitutive PYK1 promoter, a weak constitutive CYC1 promoter, or an inducible 
GAL1 promoter (Figure 3.3A). By transforming pSH47 and expressing Cre recombinase 
under galactose growth conditions, the integrated selection marker and promoter between 
the two loxP sites are excised, leaving the 3×FLAG epitope tagged target gene with the 
endogenous promoter and a loxP site (Figure 3.3A).  
The pK3F construct was validated by N-terminal 3×FLAG tagging Set1. The 
pK3F cassette was PCR amplified with Set1 primers (3×FLAG-SET1-F and 3×FLAG-
SET1-R) and genomic integration was validated using the SET1-271F and KAN-001R 
primers (Table 3.1 and data not shown). To determine if the 3×FLAG epitope tag and the 
remaining loxP site affected the transcript levels of SET1, quantitative real-time PCR 
(qRT-PCR) analysis was performed (Figure 3.4A). Transcript levels of SET1 were 
normalized to Actin (ACT1) and a WT untagged strain. Importantly, no significant 
transcript differences are detected between the WT strain and the 3×FLAG-SET1 strain. 
Western blot analysis using the monoclonal M2 FLAG antibody showed that the tagged 
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Set1 protein is expressed and detected in the 3×FLAG-SET1 strain, but not in WT or 
set1Δ strains (Figure 3.4B). Because Set1 is a histone H3K4 methyltransferase whose 
activity is inhibited when tagged at the C terminus, but not N-terminus (109, 169, 178), 
H3K4 methylation levels were analyzed (Figure 3.4B). H3K4 trimethylation levels in the 
3×FLAG-SET1 strain is similar to that of a WT strain, indicating that the 3×FLAG tag 
did not disrupt or alter the methyltransferase activity of Set1. Histone H3 was used as a 
loading control. 
To validate the pK3F-PYK1 and pK3F-GAL1 N-ICE constructs, the Set2 histone 
H3K36 methyltransferase was N-terminal 3×FLAG-tagged. The pK3F, pK3F-PYK1, and 
pK3F-GAL1 cassettes were PCR amplified with Set2 primers (3×FLAG-SET2-F and 
3×FLAG-SET2-R) and the integrations were validated using the SET2-001F and KAN-
001R primers (Table 3.1 and data not shown). To determine transcript levels of SET2 
under different promoters, quantitative real-time PCR (qRT-PCR) analysis was 
performed (Figure 3.4C). Transcript levels of SET2 were normalized to Actin (ACT1) and 
set relative to a WT untagged strain. Transcript levels of 3×FLAG-SET2 driven from the 
PYK1 promoter and the induced GAL1 promoter are significantly higher than the WT 
strain and the endogenously tagged 3×FLAG-SET2 strain (Figure 3.4C). Additionally, the 
SET2 transcript level is repressed under the GAL1 promoter when grown under glucose 
conditions compared to the WT untagged strain (Figure 3.4C). Immunoblots using the 
monoclonal M2 FLAG antibody determined that Set2 is highly expressed from the 
constitutive PYK1 promoter and when the GAL1 promoter is induced (Figure 3.4D, lanes 
3 and 5). The immunoreactive bands are specific for the 3×FLAG-tagged Set2 since Set2 
is not detected in the WT strain, the strain containing the integrated pK3F cassette prior 
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to Cre excision, or the strain containing the integrated pK3F-GAL1 cassette under 
uninduced growth conditions (Figure 3.4D, lanes 1, 2, and 4). The asterisks mark likely 
protein degradation products of Set2 when Set2 is overexpressed. Importantly, the 
removal of the KanMX selection marker by Cre recombinase showed that all the 
3×FLAG-tagged Set2 strains are expressed at similar levels regardless of whether they 
were initially tagging using pK3F, pK3F-PYK1, and pK3F-GAL1 vectors (Figure 3.4D, 
lanes 6-8, and Figure 3.7A). G6PDH was used as a loading control. Set2 is the only 
histone H3K36 methyltransferase in S. cerevisiae, and the deletion of SET2 abolishes all 
H3K36 methylation (190, 191). To determine whether the 3×FLAG-Set2 is still 
functional in yeast, the in vivo histone H3K36 trimethylation levels were determined by 
Western blot (Figure 3.4E). As expected, the H3K36 trimethylation is abolished in the 
integrated pK3F transformed cells prior to excision of loxP sites since SET2 expression is 
abolished (Figure 3.4E, lane 2 and Figure 3.4D, lane 2). The H3K36 trimethylation level 
is also abolished in the GAL1p-3×FLAG-SET2 containing strain when grown under 
glucose-repressed conditions, but is recovered in galactose-inducible conditions (Figure 
3.4E, lane 4 versus lane 5). There is no loss of H3K36 trimethylation using the pK3F-
PYK1 (Figure 3.4E, lane 3). In addition, the removal of the KanMX selection marker by 
Cre recombinase showed that all the 3×FLAG-tagged SET2 strains had H3K36 
trimethylation levels similar to a WT strain (Figure 3.4E, lanes 6-8). H3 was used as a 
loading control. 
To determine if the N-ICE plasmid system can be used to tag essential genes, 
PKC1 and ERG11 were N-terminal 3×FLAG-tagged. The PKC1 gene encodes a homolog 
of the mammalian protein kinase C (PKC) and is essential for yeast cell growth (192). 
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The ERG11 gene encodes a cytochrome P450 lanosterol demethylase and is essential for 
the ergosterol biosynthesis pathway and cell viability (193). The PKC1 and ERG11 
integration cassettes were amplified from the pH3F-PYK1 construct using the 3×FLAG-
PKC1-F and 3×FLAG-PKC1-R or 3×FLAG-ERG11-F and 3×FLAG-ERG11-R primers 
(P1 and P2 primer sets), and the integrations were validated using the PKC1-001F and 
HYG-001R primers, or by using the ERG11-001F and HYG-001R primers, respectively 
(Table 3.1 and data not shown). To determine the transcript levels of PKC1 and ERG11 
under the PYK1 promoter or the endogenous promoter, quantitative real-time PCR (qRT-
PCR) analysis was performed (Figure 3.5A and B). Transcript levels of PKC1 and 
ERG11 were normalized to Actin (ACT1) and relative to a WT untagged strain. The 
transcript levels of 3×FLAG-PKC1 and 3×FLAG-ERG11 from the PYK1 promoter are 
significantly higher than the WT strain (Figure 3.5A and B). PKC1 and ERG11 transcript 
levels from the 3×FLAG-PKC1 and 3×FLAG-ERG11 strains, respectively, are not 
significantly different compared to the WT untagged strain (Figure 3.5A and B). This 
indicates the insertion of 3×FLAG epitope tag does not affect the transcript levels of the 
target gene. Immunoblots using the monoclonal M2 FLAG antibody determined that 
Pkc1 is overexpressed from the constitutive PYK1 promoter (Figure 3.5C, lanes 1 and 2) 
when compared to endogenous expression (Figure 3.5C, lanes 3 and 4, and Figure 3.7B). 
The Erg11 expression under the PYK1 promoter is increased about two fold compared to 
the expression under the endogenous promoter (Figure 3.5D, lanes 1 and 2 vs. 3 and 4, 
and Figure 3.7C). A serial dilution spot assay showed that overexpression of 3×FLAG-
Erg11 or 3×FLAG-Pkc1 under the control of the PYK1 promoter did not affect yeast 
viability and grew similar to the WT strain (Figure 3.5E).  
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In order to test whether our second generation N-ICE plasmids can be applied to 
tag essential genes, the PKC1 gene was N-terminal 3×FLAG-tagged using the S1 and S4 
primer set. Integration cassettes were PCR amplified from the following plasmids 
pK3FS-PYK1, pK3FS-CYC1, pH3FS-PYK1, and pN3FS-CYC1 using the 3×FLAG-
PKC1-S1-F and 3×FLAG-PKC1-S4-R primers. The integrated cassettes were validated 
by PCR (data not shown). To determine the transcript levels of PKC1 under different 
promoters, the qRT-PCR analysis was performed. The transcript levels of PKC1 
expressed from the PYK1 promoter (pK3FS-PYK1 and pH3FS-PYK1) are significantly 
higher than the untagged WT strain (Figure 3.6A). The transcript levels of PKC1 
expressed from CYC1 promoters (pK3FS-CYC1 and pN3FS-CYC1) are about three fold 
higher than the untagged WT strain (Figure 3.6B). The transcript levels of 3×FLAG-
PKC1 expressed from the endogenous promoter are not significantly different than the 
untagged WT strain (Figure 3.6A and B). Immunoblots using the monoclonal M2 FLAG 
antibody determined that the Pkc1 protein levels from the PYK1 promoter (Igure 3.6C 
and D, lanes 1 and 2 and Figure 3.7D and E) are significantly higher than Pkc1 expressed 
endogenously (Figure 3.6C and D, lanes 5 and 6 and Figure 3.7D and E). As expected, 
the protein level of Pkc1 expressed from the weak constitutive CYC1 promoter is higher 
than Pkc1 expressed from the endogenous promoter but lower than Pkc1 expressed from 
the strong constitutive PYK1 promoter (Figure 3.6C and D, and Figure 3.7D and E).  
 Discussion 
We have generated the N-ICE plasmid system for generating N-terminal 3×FLAG 
epitope tagged essential and non-essential genes. These new N-ICE plasmids allow the 
tagged gene of interest to be expressed from the endogenous promoter or overexpressed 
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from a constitutive PYK1, CYC1 or inducible GAL1 promoter. Because N-ICE plasmids 
can be readily modified, the N-ICE system can be further diversified with different 
selection markers, promoters, or epitope tags. Overall, we have provided a new and 
valuable N-ICE plasmid system for the yeast community and expanded the toolbox for 
epitope tagging.  
 Materials and methods 
Strains and growth media 
All yeast strains were derived from S. cerevisiae BY4741 (MATa his3∆1 leu2∆0 
met15∆0 ura3∆0). Yeast cells were grown at 30 °C in YPD medium (1% yeast extract, 
2% peptone, 2% glucose) or synthetic complete (SC) medium with amino acid dropouts 
(194). Geneticin (G418, GoldBio) was used at the final concentration of 200 μg/ml for 
antibiotic selection of the KanMX cassette. Hygromycin B (Gibico, Thermo Fisher 
Scientific) was used at the final concentration of 300 μg/ml for antibiotic selection of the 
HphMX cassette. Nourseothricin Sulfate (GoldBio) was used at the final concentration of 
100 μg/ml for antibiotic selection of the NatMX cassette.  
Plasmid construction  
Oligonucleotides encoding the 3×FLAG epitope sequence, 3×FLAG-T and 
3×FLAG-B (Table 3.1), were annealed, generating overhanging ends compatible with 
SalI and BamHI. The annealed oligonucleotides were ligated into the SalI and BamHI 
sites of pUG6-myc-N-Avitag (183) to generate pUG6-3×FLAG. The KanMX cassette 
with the Ashbya gossypii TEF (AgTEF) promoter and AgTEF terminator was amplified 
from the pUG6-myc-N-Avitag plasmid using the KAN-1F and KAN-2R primers. The 
HphMX cassette with the AgTEF promoter and AgTEF terminator were amplified from 
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the pAG32 plasmid (168) also using the KAN-1F and KAN-2R primers. The PCR 
amplification product was purified and digested with SalI and BglII, and ligated into 
XhoI and BglII sites of pUG6-3×FLAG to generate the pK3F and pH3F plasmids. The 
PYK1 and GAL1 promoters were PCR amplified from yeast BY4741 genomic DNA, 
using the PYK1-F and PYK1-R or the GAL1-F and GAL1-R primers, respectively. The 
PCR products were digested with SpeI and XbaI and ligated into the XbaI site of the 
pK3F or pH3F plasmids to generate the pK3F-PYK1 and pK3F-GAL1, or pH3F-PYK1 
and pH3F-GAL1 plasmids, respectively.  
To incorporate the S1 and S4 primer sets in our tagging system, integration 
cassettes were amplified using primers containing S1 and S4 sites and ligated to the 
plasmid backbone. To generate pK3FS, pK3FS-PYK1, and pK3FS-GAL1, integration 
cassettes from pK3F, pK3F-PYK1, and pK3F-GAL1 were amplified using S1-001F and 
S4-003R primer sets. The PCR products were digested with NotI and XhoI and ligated in 
the NotI and XhoI sites of the pUG6 PCR product. The pUG6 PCR product was 
generated from the pUG6-myc-N-Avitag using pUG-003F and pUG-002R primer sets. 
To generate the pH3FS, pH3FS-PYK1, and pH3FS-GAL1 vectors and switch the 
terminator to the Ashbya gossypii ADH1 (AgADH1) terminator, the HphMX cassette was 
amplified by S1-001F and HphMX-001R from pH3F, digested with NotI and BglII, and 
ligated in the NotI and BglII sites of pK3FS, pK3FS-PYK1, and pK3FS-GAL1. To 
generate the pK3FS-CYC1 vector, the CYC1 promoter was PCR amplified using CYC1-
001F and CYC1-002R from Saccharomyces cerevisiae genomic DNA, digested with 
BglII and XbaI, and ligated in the BglII and XbaI sites of pK3FS-PYK1. The NatMX 
cassette with the Saccharomyces cerevisiae ADH1 (ScADH1) terminator was amplified 
75 
 
from the pAG25 plasmid using the KAN-1F and NatMX-001R primers (168). The PCR 
amplification product was purified and digested with SalI and BglII, and ligated into 
XhoI and BglII sites of pUG6-3×FLAG to generate the pN3F plasmid. To generate the 
pN3FS-CYC1 vector, the NatMX cassette was amplified by S1-001F and NatMX-001R 
from pN3F and digested with NotI and BglII, and ligated in the NotI and BglII sites of 
pK3FS-CYC1. All constructs were verified by PCR and DNA sequencing.  
PCR amplification of the N-terminal 3×FLAG-tagging cassette for genomic 
integration 
The PCR conditions used were denaturation at 95 °C for 5 min; 95 °C for 30 s, 
55 °C for 30 s, 72 °C for 2 min for a total of 30 cycles, followed by a final elongation 
step at 72 °C for 10 min. The final PCR product was purified from an agarose gel and 
ethanol precipitation. 
Yeast transformation and excision of the integration cassette 
Yeast strain BY4741 was transformed with the purified PCR product and selected 
on YPD plates with designated antibiotics. The colonies were verified by genomic PCR 
amplification (195). Once verified, the pSH47 plasmid containing the Cre recombinase 
under the GAL1 promoter was transformed into the N-terminal 3×FLAG tagged strain 
and selected on a SC-Ura plate (180). The colonies were streaked on SC-Ura plates. A 
single colony was inoculated into 5 mL of SC-Ura media and grown at 30 °C overnight. 
To induce Cre expression, 5 μL of the overnight culture was diluted into 5 mL of SC-Ura 
media containing 2% galactose (the sole carbon source) and incubated for 5 hours at 
30 °C with agitation at 250rpm. The Cre recombinase expressed cells (5 μl) were mixed 
with 100 μL of water and plated onto YPD plates. To verify the selection marker 
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excision, colonies were streaked onto both a YPD plate and a YPD plate with designated 
antibiotics. The colonies that grew on YPD plates, but not the YPD plates containing 
antibiotics, were selected for PCR verification. PCR validated strains were streaked onto 
a 5-FOA plate to counter select for the pSH47 Cre plasmid.  
Gene expression analysis 
RNA transcript levels were determined using quantitative real-time PCR (qRT-
PCR) as previously described (133). Three technical repeats were performed for each of 
the three biological repeats. All CT values were analyzed by normalizing values to 
ACT1 and setting the transcript levels of targeted genes relative to the transcript level in 
an untagged WT strain. The primer sequences for SET1, SET2, PKC1, ERG11, and ACT1 
are found in Table 3.1. 
Western blot analysis and antibodies used 
Yeast extraction and Western blot analysis to detect the 3×FLAG tagged proteins 
were performed as described previously (113, 119, 169). The α-FLAG mouse antibody 
(Sigma, M2) was used at 1:5,000. The glucose-6-phosphate dehydrogenase (G6PDH) 
rabbit antibody (Sigma, A9521) was used at 1:50,000. The α-H3K36me3 rabbit antibody 
(Abcam, Ab9050) was used at 1:5,000. The α-H3 rabbit antibody (Active Motif, 39163) 
was used at 1:5,000. The α-H3K4me3 rabbit antibody (Active Motif, 39159) was used at 
































































































SET1-001F (GE) 5’-CACACGCGTCTTCTGGTTCAT-3’ 
SET1-002R (GE) 5’-TGATAGTGACCAGAACGCGAAT-3’ 
SET2-001F (GE) 5’-ACGTCGCAGCCAGCAAA-3’ 
SET2-002R (GE) 5’-TCTCCCAGCCTGGAGGTAATC-3’ 
ACT1-001F (GE) 5’-TGGATTCCGGTGATGGTGTT-3’ 
ACT1-002R (GE) 5’-TCAAAATGGCGTGAGGTAGAGA-3’ 
KAN-001R (V) 5’-ATCGCAGTGGTGAGTAACCAT-3’ 
HYG-001R (V) 5’-ATCAGCAATCGCGCATATG-3’ 
NAT-002R (V) 5’-GGCGGTGACGCGGAAGAC-3’ 
SET1-271F (V) 5’-GGACACTTGCGATTCTAGCT-3’ 
SET2-001F (V) 5’-CGTGATCAATATCACCTTTAACG-3’ 
PKC1-001F (V) 5’-GGCTGAGTAGAGACTGATTATTAACC-3’ 
ERG11-001F (V) 5’-GCCCTCCATGTGTATTCATTATATAAG-3’ 
 
 
*Bold and underlined sequences indicate the P1 and P2 sequences (see Figure 1)  
*Underlined and not bold sequences indicate the S1 and S4 sequences 
*GE: Gene Exp = primer sets used to verify mRNA transcript levels. 




Table 3.2 Yeast Strains and Genotype in in Chapter 3 
Yeast Strain Genotype Reference 
BY4741 MATa his3 leu20 LYS2 met150 ura30 Open Biosystems 
SDBY1420  MATa his3 leu20 LYS2 met150 ura30 
set1∆::HphMX 
This study 
SDBY1421 MATa his3 leu20 LYS2 met150 ura30 
SET1::loxP-3×FLAG-SET1 
This study 
SDBY1422 MATa his3 leu20 LYS2 met150 ura30 
set2∆:: loxP-KanMX-loxP-3×FLAG-SET2 
This study 
SDBY1423 MATa his3 leu20 LYS2 met150 ura30 
SET2::loxP-KanMX-PPYK1-loxP-3×FLAG-SET2 
This study 
SDBY1424 MATa his3 leu20 LYS2 met150 ura30 
set2∆::loxP-KanMX-PGAL1-loxP-3×FLAG-SET2 
This study 
SDBY1425 MATa his3 leu20 LYS2 met150 ura30 
SET2::loxP-3×FLAG-SET2 
This study 








SDBY1428 MATa his3 leu20 LYS2 met150 ura30 
PKC1::loxP-3×FLAG-PKC1 
This study 
SDBY1429 MATa his3 leu20 LYS2 met150 ura30 
ERG11::loxP-3×FLAG-ERG11 
This study 


























Figure 3.1 Schematic representation of N-ICE plasmids. 
The 3×FLAG epitope, the KanMX cassette, the HphMX cassette, the NatMX cassette, 
heterologous promoters (PYK1, GAL1, or CYC1), loxP sites, P1/P2 sites, and S1/S4 
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sites are indicated in the figure. The Ag (Ashbya gossypii) and the Sc (Saccharomyces 
cerevisiae) are indicated. First generation N-ICE plasmids (A-F) have P1/P2 sequences 
for PCR amplification. Second genration N-ICE plasmids (G-N) have P1/P2 and S1/S4 
primer sequences for PCR amplification. N-ICE plasmids pK3F, pH3F, pK3FS, and 




Figure 3.2 Schematic representation of integration cassettes of N-ICE plasmids. 
The  3×FLAG epitope, the KanMX cassette, the HphMX cassette, the NatMX cassette, 





Figure 3.3 N-ICE plasmid strategy and primer design for N-terminal 3×FLAG 
epitope tagging. 
(A) The flow diagram of the PCR-based N-terminal 3×FLAG epitope tagging strategy 
using N-ICE plasmids. (B) Primer design for the PCR-based N-terminal 3×FLAG 
epitope tagging strategy using N-ICE plasmids. DNA sequences of the loxP sites, 
3×FLAG epitope, P1/P2, and S1/S4 primer sequences are presented. The selection 
marker (KanMX, HphMX, and NatMX) cassette and heterologous promoter are 




Figure 3.4 N-terminal 3×FLAG epitope tagging of Set1 and Set2 using first 
generation N-ICE plasmids. 
(A) The relative transcript level of SET1 is determined by qRT-PCR analysis. 
Expression analysis is relative to wild-type (WT) cells using Actin (ACT1) as an 
internal control to normalize transcript levels. Data was analyzed from three 
biological repeats (each biological repeat has three technical replicates). Error bars 
represent the standard error of the mean and values above bars indicate fold change 
relative to untagged WT. The unpaired t-test was performed and p-value ≤ 0.05 is 
considered significant: WT vs. 3×FLAG-SET1: p = 0.4191, n=3. (B) Western blot 
analysis of whole cell extracts from N-terminal 3×FLAG tagged SET1 strain. Lane 3 
represents the sample from 3×FLAG tagged SET1 strain after Cre recombination. 
Immunoblots using α-FLAG M2 monoclonal antibodies show that 3×FLAG-Set1 is 
expressed from the endogenous SET1 promoter. WT and set1∆ are used as negative 
control. Western blot analysis of histone H3K4 trimethylation levels using H3K4 
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trimethyl-specific antibodies. Histone H3 is used as a loading control. (C) Relative 
transcript levels of SET2 expressed from different promoters and growth conditions 
are determined by qRT-PCR analysis. Expression analysis is performed as 
previously described. Cells were grown up to O.D. 0.6 in YPD medium or YP 
medium with 1% galactose for 5 hours. Data was analyzed from three biological 
repeats (each biological repeat has three technical replicates). Error bars represent 
the standard error of the mean and values above bars indicate fold change relative to 
untagged WT. The unpaired t-test was performed and p-value ≤ 0.05 is considered 
significant: WT vs. 3×FLAG-SET2: p = 0.1812, n = 3; 3×FLAG-SET2 vs. GAL1p-
3×FLAG-SET2 (Glu), p < 0.0001, n = 3; 3×FLAG-SET2 vs. GAL1p-3×FLAG-SET2 
(Gal): p < 0.0001, n = 3; 3×FLAG-SET2 vs. PYK1p-3×FLAG-SET2: p < 0.0001, n = 
3. (D) Western blot analysis of whole cell extracts from the indicated yeast strains. 
Immunoblots using α-FLAG M2 monoclonal antibodies show that the 3×FLAG-Set2 
protein is expressed from the endogenous SET2 promoter and overexpressed by the 
integrated PYK1 and GAL1 promoters. Relative protein levels were quantified (figure 
3.7A). G6PDH is used as a loading control. Lane 6, 7 and 8 represent samples were 
originated from the strain transformed with cassettes amplified from pK3F, pK3F-
PYK1, and pK3F-GAL1 respectively. Asterisks indicate likely protein degradation 
products of Set2. (E) Western blot analysis of histone H3K36 trimethylation levels 
using H3K36 trimethyl-specific antibodies. Lanes 1-8 are loaded in the same order as 




















Figure 3.5 N-terminal 3×FLAG epitope tagging of essential genes, PKC1 and 
ERG11 using first generation N-ICE plasmids. 
(A and B) The relative transcript levels of PKC1 and ERG11 are determined by qRT-
PCR analysis. Data was analyzed from three biological repeats (each biological repeat 
has three technical replicates). Error bars represent the standard error of the mean and 
values above bars indicate fold change relative to untagged WT. The unpaired t-test 
was performed and p-value ≤ 0.05 is considered significant: WT vs. 3×FLAG-PKC1: p 
= 0.1736, n = 3; 3×FLAG-PKC1 vs. PYK1p-3×FLAG-PKC1: p < 0.001, n = 3; WT vs. 
3×FLAG-ERG11: p = 0.9453, n = 3; 3×FLAG-ERG11 vs. PYK1p-3×FLAG- ERG11: p 
< 0.001, n =3. (C and D) Western blot analysis of whole cell extracts from the 
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indicated yeast strains. Immunoblots using α-FLAG M2 monoclonal antibodies show 
the protein expression levels of 3×FLAG-Pkc1 or 3×FLAG-Erg11 when overexpressed 
from the PYK1 promoter or expressed from their endogenous promoters. Lanes 3-4 
from C and D represent samples from yeast strains after Cre recombination. Relative 
protein levels were quantified (Figure 3.7 B and C). G6PDH is used as a loading 
control. The two lanes of one indicated strain represent two independent colonies. (E) 
Serial dilution spot assays on YPD plates of wild-type (BY4741) or yeast strains 















Figure 3.6 N-terminal 3×FLAG epitope tagging of essential genes PKC1 using 
second generation N-ICE plasmids. 
(A and B) The relative transcript levels of PKC1 are shown as determined by qRT-
PCR analysis. Data was analyzed from three biological repeats (each biological repeat 
has three technical replicates). Error bars represent the standard error of the mean and 
values above bars indicate fold change relative to untagged WT. The unpaired t-test 
was performed and p-value ≤ 0.05 is considered significant: WT vs. 3×FLAG-PKC1: p 
= 0.1400, n = 3; 3×FLAG-PKC1 vs. PYK1p-3×FLAG-PKC1(KanMX), p < 0.001, n = 
3; 3×FLAG-PKC1 vs. PYK1p-3×FLAG- PKC1(HygMX), p < 0.001, n = 3; 3×FLAG-
PKC1 vs. CYC1p-3×FLAG-PKC1 (KanMX): p = 0.0595, n = 3; 3×FLAG-PKC1 vs. 
CYC1p-3×FLAG-PKC1(NatMX): p = 0.0494, n = 3. (C and D) Western blot analysis 
of whole cell extracts from the indicated yeast strains. Lanes 5-6 from C and D 
represent samples from yeast strains after Cre recombination. Immunoblots using α-
FLAG M2 monoclonal antibodies show the protein expression levels of 3×FLAG-Pkc1 
when expressed from a PYK1 promoter, a CYC1 promoter or the endogenous promoter. 
Relative protein levels were quantified (see Figure 3.7 D and E). G6PDH is used as a 




Figure 3.7 Relative quantification of Western blot signal intensity of whole cell 
extracts from the indicated yeast strains. 
Densitometry quantification was performed with ImageJ. (A) Quantification of 
Western blot of whole cell extracts from the N-terminal 3×FLAG tagged SET2 strains 
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(see figure 3.4D). (B) Quantification of Western blot of whole cell extracts from the N-
terminal 3×FLAG tagged PKC1 strains (see Figure 3.5C). (C) Quantification of 
Western blot of whole cell extracts from the N-terminal 3×FLAG tagged ERG11 
strains (see figure 3.5D). (D and E) Quantification of Western blot of whole cell 
extracts from the N-terminal 3×FLAG tagged PKC1 strains using S1/S4 primer sets 
(see figure 3.6C and D). The protein levels were relative to the endogenous 3×FLAG 













CHAPTER 4. FUTURE DIRECTIONS
 Characterizing how Set1 interacts with RNAPII. 
In chapter 2, we determined that Set1 interacts Ser5-P and/or Ser7-P CTD of 
RNAPII, and Set1-RNAPII interaction is independent of Paf1 complex and most Set1-
associated subunits. However, we have not rule out the function of Swd2 in Set1-RNAPII 
interaction and whether combinations of complex subunits contribute to the Set1-RNAPII 
interaction. To determine whether Swd2 is required for Set1-RNAPII interaction, 
immunoprecipitation assay of Set1 with RNAII in deletion strain of SWD2 and 
overexpression C-terminus of Sen1 (164). To test whether Set1 is sufficient for Set1-
RNAPII interaction, in vitro binding assay of full length Set1 and CTD Ser5 
phosphorylated peptides will be performed.  
We also determined the SRIM of Set1 and requirement of SRIM for Set1-RNAPII 
interaction, however, the SRIM itself is not sufficient for the interaction. To define the 
boundary of sufficient domain, immunoprecipitation assay of more Set1 truncations and 
in vitro binding assay of full length and truncations of Set1 and CTD phosphorylated 




 Characterizing the dependency of RNAII in Set1 recruitment and Histone H3K4 
methylation 
Our set1 SRIM mutants show a great reduction of Set1-chromatin association at 
5’ without affecting set1 mutant localization at promoter and 3’ of actively transcribed 
genes, and set1 SRIM mutants fail to be recruited by RNAPII at induced PCK1 gene. To 
test whether the occupancy of SRIM mutants has genome-wide defects, ChIP-seq assay 
of full length Set1 and set1 SRIM mutants will be performed. To test whether set1 SRIM 
mutants have broader recruitment defects, other environmental stress conditions, such as 
heat shock and osmolality stress, can be also applied. 
Our data also suggest that the deposition of H3K4 trimethylation by Set1 at 
transcription start site is through a RNAII recruitment manner at PCK1 gene. To test if it 
is genome-wide defect, ChIP-seq assay of H3K4me3 in full length Set1 and set1 
YFDAAA mutant under different inducible conditions will be performed.  
We have not identified H3K4me2 defects in set1 SRIM mutants at PYK1 and 
PMA1 genes, however, it is possible that there are defects in other genes. To test this, 
ChIP-seq assay of H3K4me2 in full length Set1 and set1 YFDAAA mutant will be 
performed. 
Our combined data suggest that Set1 can also be recruited to chromatin and 
methylate H3K4 through other mechanisms independent of RNAII recruitment. The 
RNAPII-independent Set1 recruitment could be through Set1-asscoiated subunits or other 




length Set1 and set1 SRIM mutants will be analyzed in double deletion strains of SET1 
and each subunit. 
 
 Characterizing the biological function of RNAII recruitment of Set1 
In chapter 2, our growth assay shows set1 SRIM mutants have growth defects on 6-
AU plates suggesting there are potential transcriptional defects in set1 SRIM mutants. 
Future experiments, such as nuclear run-on assay, would be needed to show 
transcriptional elongation is reduced.  
Other environmental stress conditions will be tested for full-length Set1 and set1 
SRIM mutants. If we found a defect, gene expressions and ChIP assay will be applied to 
determine whether RNAPII recruitment of Set1 is required for gene expression. 
 
 N-ICE plasmid system is an expandable and valuable toolbox for yeast community. 
In Chapter 3, we have generated 14 plasmids for the N-ICE plasmid system to 
generate N-terminal 3×FLAG epitope tagged essential and non-essential genes. There 
plasmids can be readily modified, for example, the 3×FLAG epitope tag sequence can be 
switched to other epitope tags using restriction enzyme of SalI and BamHI. Also, the 
selection markers and heterogenous promoters can also be switched to other markers and 
promoter sequences. Additionally, our system also provides a method for yeast genomic 




we have provided a new and valuable N-ICE plasmid system for the yeast community 












LIST OF REFERENCES 
 
1. Waddington CH (2012) The epigenotype. 1942. Int J Epidemiol 41(1):10-13. 
2. Jablonka E & Lamm E (2012) Commentary: The epigenotype--a dynamic 
network view of development. Int J Epidemiol 41(1):16-20. 
3. Holoch D & Moazed D (2015) RNA-mediated epigenetic regulation of gene 
expression. Nat Rev Genet 16(2):71-84. 
4. McCue AD, Nuthikattu S, Reeder SH, & Slotkin RK (2012) Gene expression and 
stress response mediated by the epigenetic regulation of a transposable element 
small RNA. PLoS Genet 8(2):e1002474. 
5. Maurange C & Paro R (2002) A cellular memory module conveys epigenetic 
inheritance of hedgehog expression during Drosophila wing imaginal disc 
development. Genes Dev 16(20):2672-2683. 
6. Choy JS & Lee TH (2012) Structural dynamics of nucleosomes at single-
molecule resolution. Trends in Biochemical Sciences 37(10):425-435. 
7. Kornberg RD (1974) Chromatin structure: a repeating unit of histones and DNA. 
Science 184(4139):868-871. 
8. Luger K & Hansen JC (2005) Nucleosome and chromatin fiber dynamics. Curr 
Opin Struc Biol 15(2):188-196. 
9. Bassett A, Cooper S, Wu C, & Travers A (2009) The folding and unfolding of 
eukaryotic chromatin. Curr Opin Genet Dev 19(2):159-165. 
10. Luger K, Mader AW, Richmond RK, Sargent DF, & Richmond TJ (1997) Crystal 
structure of the nucleosome core particle at 2.8 angstrom resolution. Nature 
389(6648):251-260. 
11. Burgess RJ & Zhang ZG (2013) Histone chaperones in nucleosome assembly and 
human disease. Nature Structural & Molecular Biology 20(1):14-22. 
12. Smith S & Stillman B (1991) Stepwise assembly of chromatin during DNA 
replication in vitro. EMBO J 10(4):971-980. 
13. Andrews AJ & Luger K (2011) Nucleosome structure(s) and stability: variations 
on a theme. Annu Rev Biophys 40:99-117. 
14. Iwasaki W, et al. (2013) Contribution of histone N-terminal tails to the structure 
and stability of nucleosomes. FEBS Open Bio 3:363-369. 
15. Davey CA, Sargent DF, Luger K, Maeder AW, & Richmond TJ (2002) Solvent 
mediated interactions in the structure of the nucleosome core particle at 1.9 




16. Dorigo B, et al. (2004) Nucleosome arrays reveal the two-start organization of the 
chromatin fiber. Science 306(5701):1571-1573. 
17. Eberharter A & Becker PB (2004) ATP-dependent nucleosome remodelling: 
factors and functions. J Cell Sci 117(Pt 17):3707-3711. 
18. Flaus A & Owen-Hughes T (2001) Mechanisms for ATP-dependent chromatin 
remodelling. Curr Opin Genet Dev 11(2):148-154. 
19. Flaus A & Owen-Hughes T (2011) Mechanisms for ATP-dependent chromatin 
remodelling: the means to the end. Febs J 278(19):3579-3595. 
20. Nair SS & Kumar R (2012) Chromatin remodeling in cancer: a gateway to 
regulate gene transcription. Mol Oncol 6(6):611-619. 
21. Clapier CR & Cairns BR (2009) The biology of chromatin remodeling complexes. 
Annu Rev Biochem 78:273-304. 
22. Denslow SA & Wade PA (2007) The human Mi-2/NuRD complex and gene 
regulation. Oncogene 26(37):5433-5438. 
23. Klein BJ, et al. (2014) The Histone-H3K4-Specific Demethylase KDM5B Binds 
to Its Substrate and Product through Distinct PHD Fingers. Cell Rep 6(2):325-
335. 
24. Phillips DM & Simson P (1962) Identification of some peptides from an arginine-
rich histone and their bearing on the structure of deoxyribonucleohistone. . 
Biochem. J. (82):236-241. 
25. Allfrey VG, Faulkner R, & Mirsky AE (1962) Acetylation and Methylation of 
Histones and their Possible Role in the Regulation of RNA Synthesis. 51(5):786-
794. 
26. Suganuma T & Workman JL (2011) Signals and combinatorial functions of 
histone modifications. Annu Rev Biochem 80:473-499. 
27. Zentner GE & Henikoff S (2013) Regulation of nucleosome dynamics by histone 
modifications. Nat Struct Mol Biol 20(3):259-266. 
28. Phillips DM (1963) The presence of acetyl groups of histones. Biochem J 87:258-
263. 
29. Li B, Carey M, & Workman JL (2007) The role of chromatin during transcription. 
Cell 128(4):707-719. 
30. Vaquero A, Loyola A, & Reinberg D (2003) The constantly changing face of 
chromatin. Sci Aging Knowledge Environ 2003(14):RE4. 
31. Brownell JE & Allis CD (1996) Special HATs for special occasions: Linking 
histone acetylation to chromatin assembly and gene activation. Current Opinion 
in Genetics & Development 6(2):176-184. 
32. Brownell JE, et al. (1996) Tetrahymena histone acetyltransferase A: A homolog 
to yeast Gcn5p linking histone acetylation to gene activation. Cell 84(6):843-851. 
33. Allfrey VG, FAULKNER R, & Mirsky AE (1964) Acetylation and Methylation 
of Histones and Their Possible Role in the Regulation of RNA Synthesis. Proc. 
Natl. Acad. Sci. 51:786-794. 
34. Fukuda H, Sano N, Muto S, & Horikoshi M (2006) Simple histone acetylation 





35. Kleff S, Andrulis ED, Anderson CW, & Sternglanz R (1995) Identification of a 
gene encoding a yeast histone H4 acetyltransferase. J Biol Chem 270(42):24674-
24677. 
36. Brownell JE & Allis CD (1995) An activity gel assay detects a single, 
catalytically active histone acetyltransferase subunit in Tetrahymena macronuclei. 
Proc Natl Acad Sci U S A 92(14):6364-6368. 
37. Kouzarides T (2007) Chromatin modifications and their function. Cell 
128(4):693-705. 
38. Liu CL, et al. (2005) Single-nucleosome mapping of histone modifications in S. 
cerevisiae. PLoS Biol 3(10):e328. 
39. Hong L, Schroth GP, Matthews HR, Yau P, & Bradbury EM (1993) Studies of the 
DNA binding properties of histone H4 amino terminus. Thermal denaturation 
studies reveal that acetylation markedly reduces the binding constant of the H4 
"tail" to DNA. J Biol Chem 268(1):305-314. 
40. Mujtaba S, Zeng L, & Zhou MM (2007) Structure and acetyl-lysine recognition of 
the bromodomain. Oncogene 26(37):5521-5527. 
41. Zeng L & Zhou MM (2002) Bromodomain: an acetyl-lysine binding domain. 
Febs Letters 513(1):124-128. 
42. Filippakopoulos P & Knapp S (2012) The bromodomain interaction module. 
FEBS Lett 586(17):2692-2704. 
43. Imai S, Armstrong CM, Kaeberlein M, & Guarente L (2000) Transcriptional 
silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. 
Nature 403(6771):795-800. 
44. Yang XJ & Seto E (2008) The Rpd3/Hda1 family of lysine deacetylases: from 
bacteria and yeast to mice and men. Nat Rev Mol Cell Bio 9(3):206-218. 
45. Rossetto D, Avvakumov N, & Cote J (2012) Histone phosphorylation: a 
chromatin modification involved in diverse nuclear events. Epigenetics 
7(10):1098-1108. 
46. Rossetto D, Truman AW, Kron SJ, & Cote J (2010) Epigenetic modifications in 
double-strand break DNA damage signaling and repair. Clin Cancer Res 
16(18):4543-4552. 
47. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, & Bonner WM (1998) DNA 
double-stranded breaks induce histone H2AX phosphorylation on serine 139. J 
Biol Chem 273(10):5858-5868. 
48. Redon C, et al. (2003) Yeast histone 2A serine 129 is essential for the efficient 
repair of checkpoint-blind DNA damage. Embo Rep 4(7):678-684. 
49. Xiao A, et al. (2009) WSTF regulates the H2A.X DNA damage response via a 
novel tyrosine kinase activity. Nature 457(7225):57-62. 
50. Wei Y, Mizzen CA, Cook RG, Gorovsky MA, & Allis CD (1998) 
Phosphorylation of histone H3 at serine 10 is correlated with chromosome 
condensation during mitosis and meiosis in Tetrahymena. P Natl Acad Sci USA 
95(13):7480-7484. 
51. Wei Y, Yu LL, Bowen J, Gorovsky MA, & Allis CD (1999) Phosphorylation of 





52. Goto H, et al. (1999) Identification of a novel phosphorylation site on histone H3 
coupled with mitotic chromosome condensation. Journal of Biological Chemistry 
274(36):25543-25549. 
53. Pickart CM (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 
70:503-533. 
54. Finley D & Chau V (1991) Ubiquitination. Annu Rev Cell Biol 7:25-69. 
55. Fuchs G & Oren M (2014) Writing and reading H2B monoubiquitylation. 
Biochim Biophys Acta 1839(8):694-701. 
56. Osley MA (2006) Regulation of histone H2A and H2B ubiquitylation. Brief Funct 
Genomic Proteomic 5(3):179-189. 
57. Dover J, et al. (2002) Methylation of histone H3 by COMPASS requires 
ubiquitination of histone H2B by Rad6. J Biol Chem 277(32):28368-28371. 
58. Fingerman IM, Du HN, & Briggs SD (2008) Controlling histone methylation via 
trans-histone pathways. Epigenetics 3(5):237-242. 
59. Sun ZW & Allis CD (2002) Ubiquitination of histone H2B regulates H3 
methylation and gene silencing in yeast. Nature 418(6893):104-108. 
60. Briggs SD, et al. (2002) Gene silencing: trans-histone regulatory pathway in 
chromatin. Nature 418(6897):498. 
61. Murray K (1964) The Occurrence of Epsilon-n-methyl Lysine in Histones. 
Biochemistry-Us (3):10-15. 
62. Tessarz P, et al. (2014) Glutamine methylation in histone H2A is an RNA-
polymerase-I-dedicated modification. Nature 505(7484):564-+. 
63. Jenuwein T & Allis CD (2001) Translating the histone code. Science 
293(5532):1074-1080. 
64. Zhang Y & Reinberg D (2001) Transcription regulation by histone methylation: 
interplay between different covalent modifications of the core histone tails. Gene 
Dev 15(18):2343-2360. 
65. Wozniak GG & Strahl BD (2014) Hitting the 'mark': Interpreting lysine 
methylation in the context of active transcription. Bba-Gene Regul Mech 
1839(12):1353-1361. 
66. Lee DY, Teyssier C, Strahl BD, & Stallcup MR (2005) Role of protein 
methylation in regulation of transcription. Endocr Rev 26(2):147-170. 
67. Edwards CR, Dang WW, & Berger SL (2011) Histone H4 Lysine 20 of 
Saccharomyces cerevisiae Is Monomethylated and Functions in Subtelomeric 
Silencing. Biochemistry-Us 50(48):10473-10483. 
68. Martin GM, et al. (2014) Set5 and Set1 cooperate to repress gene expression at 
telomeres and retrotransposons. Epigenetics 9(4):513-522. 
69. Martin GM, King DA, Garcia-Nieto PE, & Morrison AJ (2014) Transcriptome 
profiling of Set5 and Set1 methyltransferases: Tools for visualization of gene 
expression. Genom Data 2:216-218. 
70. Herz HM, Garruss A, & Shilatifard A (2013) SET for life: biochemical activities 
and biological functions of SET domain-containing proteins. Trends Biochem Sci 
38(12):621-639. 
71. van Leeuwen F, Gafken PR, & Gottschling DE (2002) Dot1p modulates silencing 




72. Nguyen AT & Zhang Y (2011) The diverse functions of Dot1 and H3K79 
methylation. Genes Dev 25(13):1345-1358. 
73. Eissenberg JC & Shilatifard A (2010) Histone H3 lysine 4 (H3K4) methylation in 
development and differentiation. Developmental Biology 339(2):240-249. 
74. Shi YG & Tsukada Y (2013) The Discovery of Histone Demethylases (vol 5, 
a017947, 2013). Csh Perspect Biol 5(12). 
75. Shi Y, et al. (2004) Histone demethylation mediated by the nuclear amine oxidase 
homolog LSD1. Cell 119(7):941-953. 
76. Ramakrishnan S, et al. (2016) Counteracting H3K4 methylation modulators Set1 
and Jhd2 co-regulate chromatin dynamics and gene transcription. Nat Commun 
7:11949. 
77. Kooistra SM & Helin K (2012) Molecular mechanisms and potential functions of 
histone demethylases. Nat Rev Mol Cell Biol 13(5):297-311. 
78. Tsukada Y, et al. (2006) Histone demethylation by a family of JmjC domain-
containing proteins. Nature 439(7078):811-816. 
79. Greer EL & Shi Y (2012) Histone methylation: a dynamic mark in health, disease 
and inheritance. Nat Rev Genet 13(5):343-357. 
80. Mellor J (2006) It takes a PHD to read the histone code. Cell 126(1):22-24. 
81. Taverna SD, Li H, Ruthenburg AJ, Allis CD, & Patel DJ (2007) How chromatin-
binding modules interpret histone modifications: lessons from professional pocket 
pickers. Nature Structural & Molecular Biology 14(11):1025-1040. 
82. Shilatifard A (2008) Molecular implementation and physiological roles for 
histone H3 lysine 4 (H3K4) methylation. Curr Opin Cell Biol 20(3):341-348. 
83. Yap KL & Zhou MM (2011) Structure and Mechanisms of Lysine Methylation 
Recognition by the Chromodomain in Gene Transcription. Biochemistry-Us 
50(12):1966-1980. 
84. Smallwood A, Esteve PO, Pradhan S, & Carey M (2007) Functional cooperation 
between HP1 and DNMT1 mediates gene silencing. Gene Dev 21(10):1169-1178. 
85. Gatchalian J, et al. (2016) Structural Insight into Recognition of Methylated 
Histone H3K4 by Set3. J Mol Biol. 
86. Yu Y, Zhou H, Deng X, Wang W, & Lu H (2016) Set3 contributes to 
heterochromatin integrity by promoting transcription of subunits of Clr4-Rik1-
Cul4 histone methyltransferase complex in fission yeast. Sci Rep 6:31752. 
87. Kim T & Buratowski S (2009) Dimethylation of H3K4 by Set1 Recruits the Set3 
Histone Deacetylase Complex to 5 ' Transcribed Regions. Cell 137(2):259-272. 
88. Di Lorenzo A & Bedford MT (2011) Histone arginine methylation. FEBS Lett 
585(13):2024-2031. 
89. Wysocka J, Allis CD, & Coonrod S (2006) Histone arginine methylation and its 
dynamic regulation. Front Biosci 11:344-355. 
90. Chang BS, Chen Y, Zhao YM, & Bruick RK (2007) JMJD6 is a histone arginine 
demethylase. Science 318(5849):444-447. 
91. Di Lorenzo A & Bedford MT (2011) Histone arginine methylation. Febs Letters 
585(13):2024-2031. 





93. Becker PB (2006) Gene regulation: a finger on the mark. Nature 442(7098):31-
32. 
94. Ruthenburg AJ, Allis CD, & Wysocka J (2007) Methylation of lysine 4 on histone 
H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25(1):15-
30. 
95. Pray-Grant MG, Daniel JA, Schieltz D, Yates JR, 3rd, & Grant PA (2005) Chd1 
chromodomain links histone H3 methylation with SAGA- and SLIK-dependent 
acetylation. Nature 433(7024):434-438. 
96. Sims RJ, et al. (2005) Human but not yeast CHD1 binds directly and selectively 
to histone H3 methylated at lysine 4 via its tandem chromodomains. Journal of 
Biological Chemistry 280(51):41789-41792. 
97. Barski A, et al. (2007) High-resolution profiling of histone methylations in the 
human genome. Cell 129(4):823-837. 
98. Zhang X, et al. (2002) Structure of the neurospora SET domain protein DIM-5, a 
histone H3 lysine methyltransferase. Cell 111(1):117-127. 
99. Alvarez-Venegas R & Avramova Z (2002) SET-domain proteins of the Su(var)3-
9, E(z) and trithorax families. Gene 285(1-2):25-37. 
100. Deng P, Chen QM, Hong C, & Wang CY (2015) Histone methyltransferases and 
demethylases: regulators in balancing osteogenic and adipogenic differentiation of 
mesenchymal stem cells. Int J Oral Sci 7(4):197-204. 
101. Zhang X, et al. (2003) Structural basis for the product specificity of histone lysine 
methyltransferases. Mol Cell 12(1):177-185. 
102. Min J, Zhang X, Cheng X, Grewal SI, & Xu RM (2002) Structure of the SET 
domain histone lysine methyltransferase Clr4. Nat Struct Biol 9(11):828-832. 
103. Briggs SD, et al. (2001) Histone H3 lysine 4 methylation is mediated by Set1 and 
required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Gene 
Dev 15(24):3286-3295. 
104. Porras-Yakushi TR, Whitelegge JP, Miranda TB, & Clarke S (2005) A novel SET 
domain methyltransferase modifies ribosomal protein Rpl23ab in yeast. Journal 
of Biological Chemistry 280(41):34590-34598. 
105. Strahl BD, et al. (2002) Set2 is a nucleosomal histone H3-selective 
methyltransferase that mediates transcriptional repression. Mol Cell Biol 
22(5):1298-1306. 
106. Roguev A, et al. (2001) The Saccharomyces cerevisiae Set1 complex includes an 
Ash2 homologue and methylates histone 3 lysine 4. EMBO J 20(24):7137-7148. 
107. Nagy PL, Griesenbeck J, Kornberg RD, & Cleary ML (2002) A trithorax-group 
complex purified from Saccharomyces cerevisiae is required for methylation of 
histone H3. P Natl Acad Sci USA 99(1):90-94. 
108. Bryk M, et al. (2002) Evidence that SET1, a factor required for methylation of 
histone H3, regulates rDNA silencing in S-cerevisiae by a sir2-independent 
mechanism. Current Biology 12(2):165-170. 
109. Miller T, et al. (2001) COMPASS: a complex of proteins associated with a 





110. Mersman DP, Du HN, Fingerman IM, South PF, & Briggs SD (2012) Charge-
based Interaction Conserved within Histone H3 Lysine 4 (H3K4) 
Methyltransferase Complexes Is Needed for Protein Stability, Histone 
Methylation, and Gene Expression. Journal of Biological Chemistry 287(4):2652-
2665. 
111. Zhang K, et al. (2005) The Set1 methyltransferase opposes Ipl1 aurora kinase 
functions in chromosome segregation. Cell 122(5):723-734. 
112. Latham JA, Chosed RJ, Wang S, & Dent SY (2011) Chromatin signaling to 
kinetochores: transregulation of Dam1 methylation by histone H2B 
ubiquitination. Cell 146(5):709-719. 
113. Fingerman IM, Wu CL, Wilson BD, & Briggs SD (2005) Global loss of Set1-
mediated H3 Lys4 trimethylation is associated with silencing defects in 
Saccharomyces cerevisiae. J Biol Chem 280(31):28761-28765. 
114. Dehe PM, et al. (2006) Protein interactions within the Set1 complex and their 
roles in the regulation of histone 3 lysine 4 methylation. Journal of Biological 
Chemistry 281(46):35404-35412. 
115. Kim J, et al. (2013) The n-SET Domain of Set1 Regulates H2B Ubiquitylation-
Dependent H3K4 Methylation. Molecular Cell 49(6):1121-1133. 
116. Takahashi YH, et al. (2011) Structural analysis of the core COMPASS family of 
histone H3K4 methylases from yeast to human. Proc Natl Acad Sci U S A 
108(51):20526-20531. 
117. Lee JH & Skalnik DG (2008) Wdr82 is a C-terminal domain-binding protein that 
recruits the Setd1A Histone H3-Lys4 methyltransferase complex to transcription 
start sites of transcribed human genes. Mol Cell Biol 28(2):609-618. 
118. Tresaugues L, et al. (2006) Structural characterization of Set1 RNA recognition 
motifs and their role in histone H3 lysine 4 methylation. Journal of Molecular 
Biology 359(5):1170-1181. 
119. South PF, Fingerman IM, Mersman DP, Du HN, & Briggs SD (2010) A 
conserved interaction between the SDI domain of Bre2 and the Dpy-30 domain of 
Sdc1 is required for histone methylation and gene expression. J Biol Chem 
285(1):595-607. 
120. Chen Y, Cao F, Wan BB, Dou YL, & Lei M (2012) Structure of the SPRY 
domain of human Ash2L and its interactions with RbBP5 and DPY30. Cell Res 
22(3):598-602. 
121. Cao F, et al. (2010) An Ash2L/RbBP5 Heterodimer Stimulates the MLL1 
Methyltransferase Activity through Coordinated Substrate Interactions with the 
MLL1 SET Domain. Plos One 5(11). 
122. Yu LH, Gaitatzes C, Neer E, & Smith TE (2000) Thirty-plus functional families 
from a single motif. Protein Science 9(12):2470-2476. 
123. Patel A, Dharmarajan V, & Cosgrove MS (2008) Structure of WDR5 bound to 
mixed lineage leukemia protein-1 peptide. J Biol Chem 283(47):32158-32161. 
124. Nedea E, et al. (2008) The Glc7 phosphatase subunit of the cleavage and 
polyadenylation factor is essential for transcription termination on snoRNA genes. 




125. Halbach A, et al. (2009) Cotranslational assembly of the yeast SET1C histone 
methyltransferase complex. EMBO J 28(19):2959-2970. 
126. Shi XB, et al. (2007) Proteome-wide analysis in Saccharomyces cerevisiae 
identifies several PHD fingers as novel direct and selective binding modules of 
histone H3 methylated at either lysine 4 or lysine 36. Journal of Biological 
Chemistry 282(4):2450-2455. 
127. Murton BL, Chin WL, Ponting CP, & Itzhaki LS (2010) Characterising the 
Binding Specificities of the Subunits Associated with the KMT2/Set1 Histone 
Lysine Methyltransferase. Journal of Molecular Biology 398(4):481-488. 
128. Nislow C, Ray E, & Pillus L (1997) SET1, a yeast member of the trithorax 
family, functions in transcriptional silencing and diverse cellular processes. Mol 
Biol Cell 8(12):2421-2436. 
129. Santos-Rosa H, Bannister AJ, Dehe PM, Geli V, & Kouzarides T (2004) 
Methylation of H3 lysine 4 at euchromatin promotes Sir3p association with 
heterochromatin. Journal of Biological Chemistry 279(46):47506-47512. 
130. Venkatasubrahmanyam S, Hwang WW, Meneghini MD, Tong AHY, & Madhani 
HD (2007) Genome-wide, as opposed to local, antisilencing is mediated 
redundantly by the euchromatic factors Set1 and H2A.Z. P Natl Acad Sci USA 
104(42):16609-16614. 
131. Faucher D & Wellinger RJ (2010) Methylated H3K4, a Transcription-Associated 
Histone Modification, Is Involved in the DNA Damage Response Pathway. Plos 
Genetics 6(8). 
132. Garcia P, del Dedo JE, Ayte J, & Hidalgo E (2016) Genome-wide Screening of 
Regulators of Catalase Expression ROLE OF A TRANSCRIPTION COMPLEX 
AND HISTONE AND tRNA MODIFICATION COMPLEXES ON 
ADAPTATION TO STRESS. Journal of Biological Chemistry 291(2):790-799. 
133. South PF, Harmeyer KM, Serratore ND, & Briggs SD (2013) H3K4 
methyltransferase Set1 is involved in maintenance of ergosterol homeostasis and 
resistance to Brefeldin A. Proc Natl Acad Sci U S A 110(11):E1016-1025. 
134. Young RA (1991) Rna Polymerase-Ii. Annual Review of Biochemistry 60:689-
715. 
135. Cramer P, et al. (2008) Structure of eukaryotic RNA polymerases. Annual Review 
of Biophysics 37:337-352. 
136. Carlson M (1997) Genetics of transcriptional regulation in yeast: connections to 
the RNA polymerase II CTD. Annu Rev Cell Dev Biol 13:1-23. 
137. Nonet M, Sweetser D, & Young RA (1987) Functional Redundancy and 
Structural Polymorphism in the Large Subunit of Rna Polymerase-Ii. Cell 
50(6):909-915. 
138. Allison LA, Wong JKC, Fitzpatrick VD, Moyle M, & Ingles CJ (1988) The C-
Terminal Domain of the Largest Subunit of Rna Polymerase-Ii of Saccharomyces-
Cerevisiae, Drosophila-Melanogaster, and Mammals - a Conserved Structure with 
an Essential Function. Mol Cell Biol 8(1):321-329. 
139. Nonet ML & Young RA (1989) Intragenic and Extragenic Suppressors of 
Mutations in the Heptapeptide Repeat Domain of Saccharomyces-Cerevisiae Rna 




140. Napolitano G, Lania L, & Majello B (2014) RNA Polymerase II CTD 
Modifications: How Many Tales From a Single Tail. Journal of Cellular 
Physiology 229(5):538-544. 
141. Kizer KO, et al. (2005) A novel domain in Set2 mediates RNA polymerase II 
interaction and couples histone H3K36 methylation with transcript elongation. 
Mol Cell Biol 25(8):3305-3316. 
142. Mayer A, et al. (2012) CTD Tyrosine Phosphorylation Impairs Termination 
Factor Recruitment to RNA Polymerase II. Science 336(6089):1723-1725. 
143. Hintermair C, et al. (2016) Specific threonine-4 phosphorylation and function of 
RNA polymerase II CTD during M phase progression. Sci Rep 6:27401. 
144. Krogan NJ, et al. (2002) RNA polymerase II elongation factors of Saccharomyces 
cerevisiae: a targeted proteomics approach. Mol Cell Biol 22(20):6979-6992. 
145. Mayer A, et al. (2010) Uniform transitions of the general RNA polymerase II 
transcription complex. Nat Struct Mol Biol 17(10):1272-1278. 
146. Wade PA, et al. (1996) A novel collection of accessory factors associated with 
yeast RNA polymerase II. Protein Expr Purif 8(1):85-90. 
147. Crisucci EM & Arndt KM (2011) The Roles of the Paf1 Complex and Associated 
Histone Modifications in Regulating Gene Expression. Genet Res Int 2011. 
148. Robzyk K, Recht J, & Osley MA (2000) Rad6-dependent ubiquitination of 
histone H2B in yeast. Science 287(5452):501-504. 
149. Penheiter KL, Washburn TM, Porter SE, Hoffman MG, & Jaehning JA (2005) A 
posttranscriptional role for the yeast Paf1-RNA polymerase II complex is revealed 
by identification of primary targets. Molecular Cell 20(2):213-223. 
150. Krogan NJ, et al. (2003) The Paf1 complex is required for histone h3 methylation 
by COMPASS and Dot1p: Linking transcriptional elongation to histone 
methylation. Molecular Cell 11(3):721-729. 
151. Wood A, Schneider J, Dover J, Johnston M, & Shilatifard A (2003) The Paf1 
complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, 
which signals for histone methylation by COMPASS and Dot1p. Journal of 
Biological Chemistry 278(37):34739-34742. 
152. Shilatifard A (2012) The COMPASS Family of Histone H3K4 Methylases: 
Mechanisms of Regulation in Development and Disease Pathogenesis. Annual 
Review of Biochemistry, Vol 81 81:65-95. 
153. Ng HH, Robert F, Young RA, & Struhl K (2003) Targeted recruitment of Set1 
histone methylase by elongating Pol II provides a localized mark and memory of 
recent transcriptional activity. Mol Cell 11(3):709-719. 
154. Santos-Rosa H, et al. (2002) Active genes are tri-methylated at K4 of histone H3. 
Nature 419(6905):407-411. 
155. Shilatifard A (2008) Molecular implementation and physiological roles for 
histone H3 lysine 4 (H3K4) methylation. Curr Opin Cell Biol 20(3):341-348. 
156. Hughes CM, et al. (2004) Menin associates with a trithorax family histone 
methyltransferase complex and with the hoxc8 locus. Mol Cell 13(4):587-597. 
157. Milne TA, et al. (2005) MLL associates specifically with a subset of 





158. Hampsey M & Reinberg D (2003) Tails of intrigue: phosphorylation of RNA 
polymerase II mediates histone methylation. Cell 113(4):429-432. 
159. Orphanides G & Reinberg D (2002) A unified theory of gene expression. Cell 
108(4):439-451. 
160. Cole MD & Cowling VH (2008) Transcription-independent functions of MYC: 
regulation of translation and DNA replication. Nat Rev Mol Cell Biol 9(10):810-
815. 
161. Ng HH, Robert F, Young RA, & Struhl K (2003) Targeted recruitment of Set1 
histone methylase by elongating Pol II provides a localized mark and memory of 
recent transcriptional activity. Mol Cell 11(3):709-719. 
162. Wood A, Schneider J, Dover J, Johnston M, & Shilatifard A (2003) The Paf1 
complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, 
which signals for histone methylation by COMPASS and Dot1p. J Biol Chem 
278(37):34739-34742. 
163. Jones JC, et al. (2004) C-terminal repeat domain kinase I phosphorylates Ser2 and 
Ser5 of RNA polymerase II C-terminal domain repeats. J Biol Chem 
279(24):24957-24964. 
164. Nedea E, et al. (2008) The glc7 phosphatase subunit of the cleavage and 
polyadenylation factor is essential for transcription termination on snoRNA genes. 
Molecular Cell 29(5):577-587. 
165. Du HN & Briggs SD (2010) A Nucleosome Surface Formed by Histone H4, H2A, 
and H3 Residues Is Needed for Proper Histone H3 Lys(36) Methylation, Histone 
Acetylation, and Repression of Cryptic Transcription. Journal of Biological 
Chemistry 285(15):11704-11713. 
166. Gelbart ME, Rechsteiner T, Richmond TJ, & Tsukiyama T (2001) Interactions of 
Isw2 chromatin remodeling complex with nucleosomal arrays: Analyses using 
recombinant yeast histones and immobilized templates. Mol Cell Biol 21(6):2098-
2106. 
167. Winzeler EA, et al. (1999) Functional characterization of the S-cerevisiae genome 
by gene deletion and parallel analysis. Science 285(5429):901-906. 
168. Goldstein AL & McCusker JH (1999) Three new dominant drug resistance 
cassettes for gene disruption in Saccharomyces cerevisiae. Yeast 15(14):1541-
1553. 
169. Briggs SD, et al. (2001) Histone H3 lysine 4 methylation is mediated by Set1 and 
required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes 
Dev 15(24):3286-3295. 
170. Harmeyer KM, South PF, Bishop B, Ogas J, & Briggs SD (2015) Immediate 
chromatin immunoprecipitation and on-bead quantitative PCR analysis: a 
versatile and rapid ChIP procedure. Nucleic Acids Res 43(6):e38. 
171. Wach A, Brachat A, Pohlmann R, & Philippsen P (1994) New Heterologous 
Modules for Classical or Pcr-Based Gene Disruptions in Saccharomyces-
Cerevisiae. Yeast 10(13):1793-1808. 
172. Baudin A, Ozierkalogeropoulos O, Denouel A, Lacroute F, & Cullin C (1993) A 
Simple and Efficient Method for Direct Gene Deletion in Saccharomyces-




173. Johnston M, Riles L, & Hegemann JH (2002) Gene disruption. Method Enzymol 
350:290-315. 
174. Janke C, et al. (2004) A versatile toolbox for PCR-based tagging of yeast genes: 
new fluorescent proteins, more markers and promoter substitution cassettes. Yeast 
21(11):947-962. 
175. Knop M, et al. (1999) Epitope tagging of yeast genes using a PCR-based strategy: 
More tags and improved practical routines. Yeast 15(10b):963-972. 
176. De Antoni A & Gallwitz D (2000) A novel multi-purpose cassette for repeated 
integrative epitope tagging of genes in Saccharomyces cerevisiae. Gene 246(1-
2):179-185. 
177. Li SJ & Hochstrasser M (2000) The yeast ULP2 (SMT4) gene encodes a novel 
protease specific for the ubiquitin-like Smt3 protein. Mol Cell Biol 20(7):2367-
2377. 
178. Roguev A, et al. (2001) The Saccharomyces cerevisiae Set1 complex includes an 
Ash2 homologue and methylates histone 3 lysine 4. Embo J 20(24):7137-7148. 
179. Gauss R, Trautwein M, Sommer T, & Spang A (2005) New modules for the 
repeated internal and N-terminal epitope tagging of genes in Saccharomyces 
cerevisiae (vol 22, pg 1, 2005). Yeast 22(12):1011-1011. 
180. Guldener U, Heck S, Fiedler T, Beinhauer J, & Hegemann JH (1996) A new 
efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids 
Research 24(13):2519-2524. 
181. Longtine MS, et al. (1998) Additional modules for versatile and economical PCR-
based gene deletion and modification in Saccharomyces cerevisiae. Yeast 
14(10):953-961. 
182. Vorvis C, Markus SM, & Lee WL (2008) Photoactivatable GFP tagging cassettes 
for protein-tracking studies in the budding yeast Saccharomyces cerevisiae. Yeast 
25(9):651-659. 
183. van Werven FJ & Timmers HTM (2006) The use of biotin tagging in 
Saccharomyces cerevisiae improves the sensitivity of chromatin 
immunoprecipitation. Nucleic Acids Research 34(4). 
184. Zhang L, Hernan R, & Brizzard B (2001) Multiple tandem epitope tagging for 
enhanced detection of protein expressed in mammalian cells. Mol Biotechnol 
19(3):313-321. 
185. Moqtaderi Z & Struhl K (2008) Expanding the repertoire of plasmids for PCR-
mediated epitope tagging in yeast. Yeast 25(4):287-292. 
186. Noguchi C, Garabedian MV, Malik M, & Noguchi E (2008) A vector system for 
genomic FLAG epitope-tagging in Schizosaccharomyces pombe. Biotechnol J 
3(9-10):1280-1285. 
187. Khmelinskii A, Meurer M, Duishoev N, Delhomme N, & Knop M (2011) 
Seamless gene tagging by endonuclease-driven homologous recombination. PLoS 
One 6(8):e23794. 
188. Mumberg D, Muller R, & Funk M (1995) Yeast vectors for the controlled 





189. Espinet C, de la Torre MA, Aldea M, & Herrero E (1995) An efficient method to 
isolate yeast genes causing overexpression-mediated growth arrest. Yeast 
11(1):25-32. 
190. Strahl BD, et al. (2002) Set2 is a nucleosomal histone H3-selective 
methyltransferase that mediates transcriptional repression. Mol Cell Biol 
22(5):1298-1306. 
191. Du HN, Fingerman IM, & Briggs SD (2008) Histone H3 K36 methylation is 
mediated by a trans-histone methylation pathway involving an interaction 
between Set2 and histone H4. Gene Dev 22(20):2786-2798. 
192. Watanabe M, Chen CY, & Levin DE (1994) Saccharomyces-Cerevisiae Pkc1 
Encodes a Protein-Kinase-C (Pkc) Homolog with a Substrate-Specificity Similar 
to That of Mammalian Pkc. Journal of Biological Chemistry 269(24):16829-
16836. 
193. Cabello-Hurtado F, et al. (1999) Optimized expression and catalytic properties of 
a wheat obtusifoliol 14 alpha-demethylase (CYP51) expressed in yeast - 
Complementation of erg11 Delta yeast mutants by plant CYP51. Eur J Biochem 
262(2):435-446. 
194. Sherman F (2002) Getting started with yeast. Method Enzymol 350:3-41. 
195. Gietz D, Stjean A, Woods RA, & Schiestl RH (1992) Improved Method for High-
Efficiency Transformation of Intact Yeast-Cells. Nucleic Acids Research 
20(6):1425-1425. 
196. Carrozza MJ, et al. (2005) Histone H3 methylation by Set2 directs deacetylation 
of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 
123(4):581-592. 
197. Keogh MC, et al. (2005) Cotranscriptional Set2 methylation of histone H3 lysine 
36 recruits a repressive Rpd3 complex. Cell 123(4):593-605. 
198. Henikoff S & Ahmad K (2005) Assembly of variant histones into chromatin. 
Annu Rev Cell Dev Bi 21:133-153. 
199. Santisteban MS, Kalashnikova T, & Smith MM (2000) Histone H2A.Z regulates 
transcription and is partially redundant with nucleosome remodeling complexes. 
Cell 103(3):411-422. 
200. Mizuguchi G, et al. (2004) ATP-Driven exchange of histone H2AZ variant 


















Appendix A Unpublished Data 
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In this study, all the experiments and analysis were performed by Yueping Zhang. 
 
The phenotypic study of epigenetics factors Rph1 in Saccharomyces cerevisiae 
 
Rph1 is a JmjC domain-containing histone demethylase, targeting H3K36 tri- and 
dimethylation, which is deposited by Set2 (190). Set2 interacts with ser2-P and Ser5-P 
CTD of RNAPII during transcription elongation, and H3K36 trimethylation recruits 
Rpd3 histone deacetylase (HDAC) which plays an important role in preventing cryptic 
transcription (196, 197).  
To determine the biological function of Rph1 in yeast growth under different 
environment stresses, the deletion of RPH1 is generated in wild-type BY4741 and 
BY4742. A growth assay was performed by spotting a 5-fold serial dilution of the 
indicated log phase yeast strains on indicated plates (Figure A1A). The result showed 
there is no growth difference between rph1Δ and wild-type cells in the tested conditions, 
including changing glucose to galactose, sucrose, ethanol, and acetate, and treatment of 
anti-fungal drug ketoconazole. Because Rph1 removes the H3K36 di- and trimethylation 
deposited by Set2, it is possible that the double deletion of RPH1 and SET2 would lead to 
a more severe phenotype. A growth assay was performed by spotting a 5-fold serial 




result showed there is a very slight growth defect of rph1Δ set2Δ strain on acetate plate 
and high salt (0.6M NaCl) plate compared to single deletion strains and wild-type strain.  
The deletion of RPH1 or double deletion of RPH1 and SET2 does not show a 
severe growth defect under the tested conditions. It is possible that Rph1 and Set2 are not 
functions in these related pathway. Different conditions, such as cryptic transcription, 






Figure A1 The growth assay of deletion of RPH1 on indicated conditions 
(A) Serial dilution spot assays wild-type (BY4741 or BY4742) or indicated strains on 
SC plate or SC with indicated carbon source or chemical. (B) Serial dilution spot 
assays wild-type (BY4741) or indicated strains on SC plate or SC with acetate or 





The phenotypic study of epigenetics factors Htz1 in Saccharomyces cerevisiae 
 
Histone Htz1(H2A.Z) is an H2A variant, functions in transcription activation and 
anti-silencing (130, 198, 199). Htz1 is deposited on the nucleosome by SWR1 complex 
replacing H2A-H2B dimer with Htz1-H2B dimer (198, 200). In Saccharomyces 
cerevisiae, Htz1 is nonessential gene, and together with H3K4 trimethylation to 
antagonize the spreading of Sir proteins (HDACs) from the silencing region (130). 
To determine the biological function of Htz1 in yeast, we generated htz1Δ in wild-
type FY2609 and BY4741 strain. A growth assay was performed by spotting a 5-fold 
serial dilution of the indicated log phase yeast strains on indicated plates (Figure A2A). 
The results showed that the deletion of HTZ1 results in a slow growth phenotype under 
acetate condition or at 24°C both in FY2609 and BY4741 background. Acetate is non-
fermentative carbon source for yeast. Because Htz1 and Set1 coincide at transcriptional 
start site, it is possible that the double deletion of HTZ1 and SET1 results in a more severe 
growth phenotype on acetate condition. A growth assay showed double deletion of HTZ1 
and SET1 is slightly slower than htz1Δ (Figure A2B).  
The deletion of HTZ1 exhibits a slightly slow growth defect when yeast are 
growing in either 24°C or 37°C which is not yeast favorite condition and in Acetate 
condition. The double deletion of HTZ1 and SET1 only showed a slightly slower than the 
single deletion. In the future, Microarray or RNA seq method will be applied to study 





Figure A2 The deletion of HTZ1 exhibits a temperature sensitive phenotype and 
slight growth defect on acetate condition 
(A) Serial dilution spot assays wild-type (FY2609 or BY4741) or indicated strains on 
SC plate with different incubation temperatures or SC with acetate as carbon source. 
(B) Serial dilution spot assays wild-type (BY4741) or indicated strains on SC plate or 





Appendix B Primers and Plasmids 
Table A1 Primers 
Set1 260 CCGACTAGTGTTTTGGCCAATTTTATTTA 
Set1 261 CGGAGATCTGTCGACACCATGGACTATAAAG 
Set1 262 CGGAAGCTTATACAGTTTAGTATTTATCTTTACC 
Set1 263 GGGCTCGAGTCAGTTTTCTGCTTCTTTCTCTTTAGCCTTCTTC 
Set1 264 GGGCTCGAGTCATATTTCACATGAAGGGGGAGGC 
Set1 265 GGGCTCGAGTCACTTTTTAAAATAGTTTTTTATTGATATGTCTTGG 




































































































































CTD F BamHI CCCCGGATCCTTTTCTCCAACTTCCCCAAC 
CTD 1R XhoI GGGGCTCGAGAGCTTAGAAGTTGGACGGACG 
S5A F GCCCGGATCCTTTTCTCCAACTGCC 
S2A F GCCCGGATCCTTTGCACCAACTTC 
CTD 2R GCGGCTCGAGAAGCTTATCTGGAATTTTC 
H3 3F GGCACTCGAGGGAAGCATGGCTAGGAC 
H3 R GTCGAGATCTCTAGACCCGGGATAAC 






















Table A2 Plasmids in Chapter 2 
Plasmids Construction 
pRS416-SET1p-3FLAG-Set1 
PCR of 3FLAG-SET1 using Set1 260F and Set1-262R, 
the PCR product was digested by SpeI and HindIII, and 
ligated to SpeI and HindIII sites of pRS416. The plasmid 




Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
298 and 299 
pRS416-SET1p-3FLAG-Set1 
(379-1080) 
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
278 and 279 
pRS416-SET1p-3FLAG-Set1 
(1-689) 
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
294 and 295 
pRS416-SET1p-3FLAG-Set1 
(690-1080) 
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
282 and 283 
pRS416-SET1p-3FLAG-Set1 
(51-1080) 
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
284 and 285 
pRS416-SET1p-3FLAG-Set1 
(102-1080) 
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
286 and 287 
pRS416-SET1p-3FLAG-Set1 
(151-1080) 
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
288 and 289 
pRS416-SET1p-3FLAG-Set1 
(211-1080) 
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
290 and 291 
pRS416-SET1p-3FLAG-Set1 
Δ(101-151) 
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
318 and 319 
pRS416-SET1p-3FLAG-Set1 
(RP->AA)  
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
320 and 321 
pRS416-SET1p-3FLAG-Set1 
(R133E)  
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
330 and 331 
pRS416-SET1p-3FLAG-Set1 
(S136A)  
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
332 and 333 
pRS416-SET1p-3FLAG-Set1 
(KFH->AAA)  
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
324 and 325 
pRS416-SET1p-3FLAG-Set1 
(YFD->AAA)  
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
326 and 327 
pRS416-SET1p-3FLAG-Set1 
Δ(KFHYFD)  
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
322 and 323 
pRS416-SET1p-3FLAG-Set1 
(H150A)  
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 
338 and 339 
pRS416-SET1p-3FLAG-Set1 
(Y151A)  
Mutagenesis of pRS416-SET1p-3FLAG-Set1 using Set1 





Table A2 continued 
pRS416-PYK1p-3FLAG-Set1  
PCR of 3FLAG-SET1 using Set1 261F and Set1-262R, 
the PCR product was digested by BglII and HindIII, and 
ligated to BamHI and HindIII sites of pRS416-PYK1.  
pRS416-PYK1p-3FLAG-Set1 
Δ(230-335) 
Mutagenesis of pRS416-PYK1p-3FLAG-Set1 using Set1 
300 and 301 
pRS425-PYK1p-3FLAG-Set1 
(1-375) 
PCR of 3FLAG-SET1 using Set1 261F and Set1-263R, 
the PCR product was digested by BglII and XhoI and 
ligated to BamHI and XhoI sites of pRS425-PYK1.  
pRS425-PYK1p-3FLAG-Set1 
(151-375) 
PCR of 3FLAG-SET1 using Set1 265F and Set1-263R, 
the PCR product was digested by BglII and XhoI and 
ligated to BamHI and XhoI sites of pRS425-PYK1.  
pRS425-PYK1p-3FLAG-Set1 
(1-275) 
PCR of 3FLAG-SET1 using Set1 261F and Set1-265R, 
the PCR product was digested by BglII and XhoI and 
ligated to BamHI and XhoI sites of pRS425-PYK1.  
pRS425-PYK1p-3FLAG-Set1 
(1-250) 
PCR of 3FLAG-SET1 using Set1 261F and Set1-264R, 
the PCR product was digested by BglII and XhoI and 
ligated to BamHI and XhoI sites of pRS425-PYK1.  
pRS415-PYK1p-NLS-GST 
PCR of pGEX using NLS-GST F and GST-TEV R, the 
PCR product digested by XbaI and BamHI, and ligated 




PCR from BY4741 genomic DNA using CTD F and 
CTD 1R, the PRC product digested by BamHI and XhoI, 




PCR from synthesized S5A plasmid using S5A F and 
CTD 2R, the PRC product digested by BamHI and XhoI, 




PCR from synthesized S5A plasmid using S2A F and 
CTD 2R, the PRC product digested by BamHI and XhoI, 










Table A3 Plasmids for generating histone mutants 
pKan-H3(1) 
PCR of synthesized H3(1) gBlock using H3_3F and H3 
R, digested by XhoI and BglII; PCR of pK3F using 
PTEF F and TTEF R, digested by NotI and BglII; and 
the two fragments ligated to the XhoI and NotI sites of 
pK3FS. 
pNat-H3(1) 
PCR of pN3FS-CYC1 using PTEF F and NatMX-001R, 
digested by NotI and BglII, and ligated to BglII, and 
NotI sites of pKan-H3(1) 
pHyg-H3(1) 
PCR of pH3FS using PTEF F and HphMX-001R, 
digested by NotI and BglII, and ligated to BglII, and 
NotI sites of pKan-H3(1) 
pHyg-H3(2) 
PCR of synthesized H3(2) gBlock using H3_4F and H3 
R, digested by XhoI and BglII, and ligated to the XhoI 
and BglII sites of pHyg-H3(1) 
pNat-H3(1) (PYK1p) 
PCR of PYK1lox71 F and PYK1 NcoI R, the PCR 
product digested by NotI and NcoI, and ligated to the 
NotI and NcoI sites of pNAT-H3(1) 
pKan-lox66-71 XhoI digestion of pKan-H3(1) and self-ligation. 
pHyg-lox66-71 XhoI digestion of pHyg-H3(1) and self-ligation. 




































LOCUS       pNat H3(1)   3763 bp    DNA   CIRCULAR SYN        06-DEC-2016 
DEFINITION  Ligation of inverted Fragment 2 into Fragment 2 
ACCESSION   pNat H3(1) 
KEYWORDS    . 
SOURCE      Unknown. 
  ORGANISM  Unknown 
            Unclassified. 
REFERENCE   1  (bases 1 to 3763) 
  AUTHORS   Self 
  JOURNAL   Unpublished. 
COMMENT     SECID/File created by SciEd Central, Scientific & Educational Software 
COMMENT     SECNOTES|Vector molecule:  Fragment 2 
               Fragment ends: NotI and NcoI 
               Fragment size: 3410 
            Insert molecule:  Fragment 2 
               Fragment ends: NotI and NcoI 
               Fragment size: 353 
FEATURES             Location/Qualifiers 
     CDS             13..423 
                     /gene="h3" 
                     /SECDrawAs="Gene" 
     CDS             complement (430..463) 
                     /gene="loxP66" 
                     /SECDrawAs="Gene" 
     CDS             complement (481..541) 
                     /gene="TscADH1" 
                     /SECDrawAs="Gene" 
     CDS             complement (542..1111) 
                     /gene="NatMX" 
                     /product="Nourseothricin acetyltransferase" 
                     /SECDrawAs="Gene" 
     CDS             complement (1117..1428) 
                     /gene="PscPYK1" 
                     /SECDrawAs="Gene" 
     CDS             complement (1429..1462) 
                     /gene="lox71" 
                     /SECDrawAs="Gene" 
BASE COUNT      951 a    938 c    981 g    893 t 
ORIGIN       
        1 ctcgagggaa gcatggctag gaccaaacag actgcgagga aatctaccgg cggaaaggct 
       61 cccaggaaac agttggcctc caaggccgct aggaagtctg caccctccac tggcggggtc 
      121 aaaaagccgc atcgttacaa acctggcacc gtcgccctaa gggagattag gcgttttcag 
      181 aagtccaccg agctactaat aaggaaacta ccctttcaga ggcttgttag ggagattgcg 
      241 caggacttta aaactgatct acgtttccag tcctccgcta ttggcgctct tcaggagtcc 
      301 gttgaggcat atttggtttc cttgttcgag gacactaatc tagctgcaat ccatgctaaa 




      421 tagctcgagt accgttcgta taatgtatgc tatacgaagt tatcccgggt ctagagatct 
      481 atacacttat tttttttata acttatttaa taataaaaat cataaatcat aagaaattcg 
      541 cttaggggca gggcatgctc atgtagagcg cctgctcgcc gtccgaggcg gtgccgtcgt 
      601 acagggcggt gtccaggccg cagagggtga accccatccg ccggtacgcg tggatcgccg 
      661 gtgcgttgac gttggtgacc tccagccaga ggtgcccggc gccccgctcg cgggcgaact 
      721 ccgtcgcgag ccccatcaac gcgcgcccga ccccgtgccc ccggtgctcc ggggcgacct 
      781 cgatgtcctc gacggtcagc cggcggttcc agccggagta cgagacgacc acgaagcccg 
      841 ccaggtcgcc gtcgtccccg tacgcgacga acgtccggga gtccgggtcg ccgtcctccc 
      901 cgtcgtccga ttcgtcgtcc gattcgtcgt cggggaacac cttggtcagg ggcgggtcca 
      961 ccggcacctc ccgcagggtg aagccgtccc cggtggcggt gacgcggaag acggtgtcgg 
     1021 tggtgaagga cccatccagt gcctcgatgg cctcggcgtc ccccgggaca ctggtgcggt 
     1081 accggtaagc cgtgtcgtca agagtggtac ccatggtgtg atgatgtttt atttgttttg 
     1141 attggtgtct tgtaaataga aacaagagag aataataaac aagttaagaa taaaaaacca 
     1201 aaggatgaaa aagaatgaat atgaaaaaga gtagagaata actttgaaag gggaccatga 
     1261 tataactgga aaaaagaggt tcttggaaat gaaaagttac caaagagtat ttataattca 
     1321 gaaaaaaaag ccaacgaata tcgttttgat ggcgagcctt tttttttttt taggaagaca 
     1381 ctaaaggtac ctagcatcat atgggaagga aaggaaatca cttggaagat aacttcgtat 
     1441 aatgtatgct atacgaacgg tagcggccgc ggatctgccg gtctccctat agtgagtcgt 
     1501 attaatttcg ataagccagg ttaacctgca ttaatgaatc ggccaacgcg cggggagagg 
     1561 cggtttgcgt attgggcgct cttccgcttc ctcgctcact gactcgctgc gctcggtcgt 
     1621 tcggctgcgg cgagcggtat cagctcactc aaaggcggta atacggttat ccacagaatc 
     1681 aggggataac gcaggaaaga acatgtgagc aaaaggccag caaaaggcca ggaaccgtaa 
     1741 aaaggccgcg ttgctggcgt ttttccatag gctccgcccc cctgacgagc atcacaaaaa 
     1801 tcgacgctca agtcagaggt ggcgaaaccc gacaggacta taaagatacc aggcgtttcc 
     1861 ccctggaagc tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg gatacctgtc 
     1921 cgcctttctc ccttcgggaa gcgtggcgct ttctcaatgc tcacgctgta ggtatctcag 
     1981 ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg ttcagcccga 
     2041 ccgctgcgcc ttatccggta actatcgtct tgagtccaac ccggtaagac acgacttatc 
     2101 gccactggca gcagccactg gtaacaggat tagcagagcg aggtatgtag gcggtgctac 
     2161 agagttcttg aagtggtggc ctaactacgg ctacactaga aggacagtat ttggtatctg 
     2221 cgctctgctg aagccagtta ccttcggaaa aagagttggt agctcttgat ccggcaaaca 
     2281 aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag cagattacgc gcagaaaaaa 
     2341 aggatctcaa gaagatcctt tgatcttttc tacggggtct gacgctcagt ggaacgaaaa 
     2401 ctcacgttaa gggattttgg tcatgagatt atcaaaaagg atcttcacct agatcctttt 
     2461 aaattaaaaa tgaagtttta aatcaatcta aagtatatat gagtaaactt ggtctgacag 
     2521 ttaccaatgc ttaatcagtg aggcacctat ctcagcgatc tgtctatttc gttcatccat 
     2581 agttgcctga ctccccgtcg tgtagataac tacgatacgg gagggcttac catctggccc 
     2641 cagtgctgca atgataccgc gagacccacg ctcaccggct ccagatttat cagcaataaa 
     2701 ccagccagcc ggaagggccg agcgcagaag tggtcctgca actttatccg cctccatcca 
     2761 gtctattaat tgttgccggg aagctagagt aagtagttcg ccagttaata gtttgcgcaa 
     2821 cgttgttgcc attgctacag gcatcgtggt gtcacgctcg tcgtttggta tggcttcatt 
     2881 cagctccggt tcccaacgat caaggcgagt tacatgatcc cccatgttgt gcaaaaaagc 
     2941 ggttagctcc ttcggtcctc cgatcgttgt cagaagtaag ttggccgcag tgttatcact 
     3001 catggttatg gcagcactgc ataattctct tactgtcatg ccatccgtaa gatgcttttc 
     3061 tgtgactggt gagtactcaa ccaagtcatt ctgagaatag tgtatgcggc gaccgagttg 




     3181 catcattgga aaacgttctt cggggcgaaa actctcaagg atcttaccgc tgttgagatc 
     3241 cagttcgatg taacccactc gtgcacccaa ctgatcttca gcatctttta ctttcaccag 
     3301 cgtttctggg tgagcaaaaa caggaaggca aaatgccgca aaaaagggaa taagggcgac 
     3361 acggaaatgt tgaatactca tactcttcct ttttcaatat tattgaagca tttatcaggg 
     3421 ttattgtctc atgagcggat acatatttga atgtatttag aaaaataaac aaataggggt 
     3481 tccgcgcaca tttccccgaa aagtgccacc tgacgtctaa gaaaccatta ttatcatgac 
     3541 attaacctat aaaaataggc gtatcacgag gccctttcgt ctcgcgcgtt tcggtgatga 
     3601 cggtgaaaac ctctgacaca tgcagctccc ggagacggtc acagcttgtc tgtaagcgga 
     3661 tgccgggagc agacaagccc gtcagggcgc gtcagcgggt gttggcgggt gtcggggctg 


































LOCUS       pHyg-H3(2)   4276 bp    DNA   CIRCULAR SYN        06-DEC-2016 
DEFINITION  Ligation of Fragment 2 into Fragment 3 
ACCESSION   pHyg-H3(2) 
KEYWORDS    . 
SOURCE      Unknown. 
  ORGANISM  Unknown 
            Unclassified. 
REFERENCE   1  (bases 1 to 4276) 
  AUTHORS   Self 
  JOURNAL   Unpublished. 
COMMENT     SECID/File created by SciEd Central, Scientific & Educational Software 
COMMENT     SECNOTES|Vector molecule:  Fragment 3 
               Fragment ends: BglII and XhoI 
               Fragment size: 3796 
            Insert molecule:  Fragment 2 
               Fragment ends: XhoI and BglII 
               Fragment size: 480 
FEATURES             Location/Qualifiers 
     CDS             25..435 
                     /gene="H3(2)" 
                     /SECDrawAs="Gene" 
     CDS             436..469 
                     /gene="lox66" 
                     /SECDrawAs="Gene" 
     CDS             complement (487..543) 
                     /gene="TagADH1" 
                     /SECDrawAs="Gene" 
     CDS             complement (544..1572) 
                     /gene="HphMX " 
                     /SECDrawAs="Gene" 
     CDS             complement (1573..1939) 
                     /gene="PagTEF" 
                     /SECDrawAs="Gene" 
     CDS             complement (1942..1975) 
                     /gene="Lox71" 
                     /SECDrawAs="Gene" 
BASE COUNT     1073 a   1090 c   1109 g   1004 t 
ORIGIN       
        1 ctcgagcgta cgctgcaggt cgacatggca cgtacgaagc agaccgcccg taagagtacg 
       61 ggaggcaaag cacctcgtaa gcagcttgca agtaaagcag cgcgtaagag cgctcctagc 
      121 acaggaggcg taaaaaaacc acataggtac aaacccggaa cagtagcatt acgtgagata 
      181 cgtaggtttc agaagagcac agagcttctt attcgtaaac ttccatttca gcgtctagta 
      241 cgtgagattg cccaggactt taaaacagat ttaaggttcc agagctcagc aataggagca 




      361 atacatgcaa aaagagtaac aattcagaaa aaagacataa agctagcacg taggttgagg 
      421 ggagagcgtt cttgataccg ttcgtataat gtatgctata cgaagttatc ccgggtctag 
      481 agatctaaaa gtcaggcgat cacacattaa aagctataca ttacaaagcg ttaatagcgg 
      541 gcattattcc tttgccctcg gacgagtgct ggggcgtcgg tttccactat cggcgagtac 
      601 ttctacacag ccatcggtcc agacggccgc gcttctgcgg gcgatttgtg tacgcccgac 
      661 agtcccggct ccggatcgga cgattgcgtc gcatcgaccc tgcgcccaag ctgcatcatc 
      721 gaaattgccg tcaaccaagc tctgatagag ttggtcaaga ccaatgcgga gcatatacgc 
      781 ccggagccgc ggcgatcctg caagctccgg atgcctccgc tcgaagtagc gcgtctgctg 
      841 ctccatacaa gccaaccacg gcctccagaa gaagatgttg gcgacctcgt attgggaatc 
      901 cccgaacatc gcctcgctcc agtcaatgac cgctgttatg cggccattgt ccgtcaggac 
      961 attgttggag ccgaaatccg cgtgcacgag gtgccggact tcggggcagt cctcggccca 
     1021 aagcatcagc tcatcgagag cctgcgcgac ggacgcactg acggtgtcgt ccatcacagt 
     1081 ttgccagtga tacacatggg gatcagcaat cgcgcatatg aaatcacgcc atgtagtgta 
     1141 ttgaccgatt ccttgcggtc cgaatgggcc gaacccgctc gtctggctaa gatcggccgc 
     1201 agcgatcgca tccatggcct ccgcgaccgg ctgcagaaca gcgggcagtt cggtttcagg 
     1261 caggtcttgc aacgtgacac cctgtgcacg gcgggagatg caataggtca ggctctcgct 
     1321 gaattcccca atgtcaagca cttccggaat cgggagcgcg gccgatgcaa agtgccgata 
     1381 aacataacga tctttgtaga aaccatcggc gcagctattt acccgcagga catatccacg 
     1441 ccctcctaca tcgaagctga aagcacgaga ttcttcgccc tccgagagct gcatcaggtc 
     1501 ggagacgctg tcgaactttt cgatcagaaa cttctcgaca gacgtcgcgg tgagttcagg 
     1561 ctttttaccc atggttgttt atgttcggat gtgatgtgag aactgtatcc tagcaagatt 
     1621 ttaaaaggaa gtatatgaaa gaagaacctc agtggcaaat cctaaccttt tatatttctc 
     1681 tacaggggcg cggcgtgggg acaattcaac gcgtctgtga ggggagcgtt tccctgctcg 
     1741 caggtctgca gcgaggagcc gtaatttttg cttcgcgccg tgcggccatc aaaatgtatg 
     1801 gatgcaaatg attatacatg gggatgtatg ggctaaatgt acgggcgaca gtcacatcat 
     1861 gcccctgagc tgcgcacgtc aagactgtca aggagggtat tctgggcctc catgtcgctg 
     1921 gccgggtgac ccggcgggga cataacttcg tataatgtat gctatacgaa cggtagcggc 
     1981 cgcggatctg ccggtctccc tatagtgagt cgtattaatt tcgataagcc aggttaacct 
     2041 gcattaatga atcggccaac gcgcggggag aggcggtttg cgtattgggc gctcttccgc 
     2101 ttcctcgctc actgactcgc tgcgctcggt cgttcggctg cggcgagcgg tatcagctca 
     2161 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtg 
     2221 agcaaaaggc cagcaaaagg ccaggaaccg taaaaaggcc gcgttgctgg cgtttttcca 
     2281 taggctccgc ccccctgacg agcatcacaa aaatcgacgc tcaagtcaga ggtggcgaaa 
     2341 cccgacagga ctataaagat accaggcgtt tccccctgga agctccctcg tgcgctctcc 
     2401 tgttccgacc ctgccgctta ccggatacct gtccgccttt ctcccttcgg gaagcgtggc 
     2461 gctttctcaa tgctcacgct gtaggtatct cagttcggtg taggtcgttc gctccaagct 
     2521 gggctgtgtg cacgaacccc ccgttcagcc cgaccgctgc gccttatccg gtaactatcg 
     2581 tcttgagtcc aacccggtaa gacacgactt atcgccactg gcagcagcca ctggtaacag 
     2641 gattagcaga gcgaggtatg taggcggtgc tacagagttc ttgaagtggt ggcctaacta 
     2701 cggctacact agaaggacag tatttggtat ctgcgctctg ctgaagccag ttaccttcgg 
     2761 aaaaagagtt ggtagctctt gatccggcaa acaaaccacc gctggtagcg gtggtttttt 
     2821 tgtttgcaag cagcagatta cgcgcagaaa aaaaggatct caagaagatc ctttgatctt 
     2881 ttctacgggg tctgacgctc agtggaacga aaactcacgt taagggattt tggtcatgag 
     2941 attatcaaaa aggatcttca cctagatcct tttaaattaa aaatgaagtt ttaaatcaat 




     3061 tatctcagcg atctgtctat ttcgttcatc catagttgcc tgactccccg tcgtgtagat 
     3121 aactacgata cgggagggct taccatctgg ccccagtgct gcaatgatac cgcgagaccc 
     3181 acgctcaccg gctccagatt tatcagcaat aaaccagcca gccggaaggg ccgagcgcag 
     3241 aagtggtcct gcaactttat ccgcctccat ccagtctatt aattgttgcc gggaagctag 
     3301 agtaagtagt tcgccagtta atagtttgcg caacgttgtt gccattgcta caggcatcgt 
     3361 ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc ggttcccaac gatcaaggcg 
     3421 agttacatga tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc ctccgatcgt 
     3481 tgtcagaagt aagttggccg cagtgttatc actcatggtt atggcagcac tgcataattc 
     3541 tcttactgtc atgccatccg taagatgctt ttctgtgact ggtgagtact caaccaagtc 
     3601 attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa tacgggataa 
     3661 taccgcgcca catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt cttcggggcg 
     3721 aaaactctca aggatcttac cgctgttgag atccagttcg atgtaaccca ctcgtgcacc 
     3781 caactgatct tcagcatctt ttactttcac cagcgtttct gggtgagcaa aaacaggaag 
     3841 gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa tgttgaatac tcatactctt 
     3901 cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg gatacatatt 
     3961 tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc acatttcccc gaaaagtgcc 
     4021 acctgacgtc taagaaacca ttattatcat gacattaacc tataaaaata ggcgtatcac 
     4081 gaggcccttt cgtctcgcgc gtttcggtga tgacggtgaa aacctctgac acatgcagct 
     4141 cccggagacg gtcacagctt gtctgtaagc ggatgccggg agcagacaag cccgtcaggg 
     4201 cgcgtcagcg ggtgttggcg ggtgtcgggg ctggcttaac tatgcggcat cagagcagat 
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